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1. Zusammenfassung 
 
Der Igf2r Cluster im Genom der Maus ist ein verbreitetes Modell zur Untersuchung 
der Stilllegung von geprägten Genen. Innerhalb dieses Clusters überlappt die 
väterlich exprimierte, lange nicht protein-kodierende RNA (macro long non-coding 
RNA, macro lncRNA) Airn mit dem Igf2r Gen in entgegengesetzter transkriptioneller 
Orientierung. Dadurch wird die väterliche Kopie des Igf2r Gens sowohl in 
embryonalen als auch in adulten Geweben stillgelegt. Die Verkürzung des 108kb 
langen Airn Transkripts auf 3kb führte zum funktionellen Verlust von Airn. Damit 
wurde gezeigt, dass Airn für die Stilllegung des Igf2r Gens unerlässlich ist. Es wurde 
jedoch noch nicht gezeigt, ob Airn auf der Ebene der Transkription funktioniert oder 
ob das Airn Transkript für die Stilllegung von Igf2r verantwortlich ist.  
Eine Reihe von Verkürzungen vom 3’-Ende zeigte dass ein Großteil des Airn-
Transkripts nicht zur Stilllegung von Igf2r benötigt wird. Um den funktionellen 
Abschnitt von Airn weiter einzuengen, wurde der Airn Promoter unmittelbar vor den  
Igf2r Promoter verschoben (forward Airn promoter, FAP). Diese Verkürzung vom 5’-
Ende hatte jedoch keinen negativen Effekt auf die Stilllegung von Igf2r. In meiner 
Diplomarbeit habe ich ein in vitro Stammzell-Differenzierungssystem verwendet, um 
den Chromatinstatus der Igf2r Promoterregion in Zellen zu untersuchen, die eine 
väterliche Kopie des FAP-Alleles tragen. Im Wildtyp ist der Igf2r Promoter 
üblicherweise methyliert und durch repressive Histonmodifikationen gekennzeichnet. 
Ich konnte jedoch zeigen, dass in differenzierten FAP-Zellen keine Methylierung des 
Igf2r Promoters stattfindet, dennoch wurde Igf2r stillgelegt. Zusätzlich zeigte der 
inaktive Igf2r Promoter eine Histonmodifikation, die mit transkriptioneller Aktivierung 
assoziiert ist. Diese Daten unterstützen die Hypothese, dass Airn nicht über die 
Interaktion mit inaktivierenden Proteinen funktioniert, sondern die Transkription durch 
den überlappten Igf2r Promoter allein ausreichend ist um Igf2r am väterlichen 
Chromosom stillzulegen.  
Weiters habe ich ein Zellkultursystem etabliert um die Stabilität von lncRNAs zu 
untersuchen. Die Halbwertszeit ist einer der Parameter um die Funktion von 
lncRNAs einzuschätzen. Eine stabile RNA indiziert eine Funktion des RNA Produkts, 
während eine instabile RNA darauf hinweist, dass die Transkription der biologisch 
relevante Mechanismus ist. In Kombination mit RNA-Sequenzierung (Next- 
Generation Sequencing) wird dieses System die genomweite Charakterisierung der 
Stabilität langer, nicht codierender RNA ermöglichen.   
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1. Abstract 
 
The mouse Igf2r cluster is a common model for studying imprinted gene 
silencing. Within the Igf2r locus, the paternally expressed macro long non-coding 
RNA (lncRNA) Airn overlaps the Igf2r promoter in antisense direction. This 
causes the silencing of Igf2r on the paternal allele in embryonic and adult tissues. 
Truncation of the 108kb Airn transcript to 3kb (Sleutels, Zwart et al. 2002) 
abolished its silencing function and thus demonstrated that Airn is required for 
silencing Igf2r. However, it is not conclusively answered if Airn functions on the 
level of transcription or if the Airn transcript is required for silencing Igf2r.  
 
A series of 3’truncations using a polyA cassette showed that the majority of the 
Airn transcript upstream of Igf2r promoter is not necessary for its silencing 
function. To further narrow down the functional length of Airn, a 5’truncation was 
created by inserting the paternal Airn promoter immediately upstream of the Igf2r 
promoter (forward Airn promoter, FAP). Notably, Airn expressed from the FAP 
allele was still able to silence Igf2r (Latos, Pauler et al. manuscript in progress). 
In my Diploma thesis, I used an in vitro stem cell system (Latos, Stricker et al. 
2009) to investigate the Igf2r promoter chromatin state in ES cells that carry a 
paternal FAP allele. In the wildtype, the paternal Igf2r promoter is methylated and 
carries repressive chromatin marks. However, I confirmed that differentiated FAP 
cells lack methylation of the paternal Igf2r promoter, but nevertheless Igf2r is 
silenced. Interestingly I found that the repressed Igf2r promoter region carries an 
active chromatin signature. These data provide support for the hypothesis that 
Airn does not recruit epigenetic silencers to the Igf2r promoter and transcriptional 
overlap between Airn and Igf2r is sufficient to silence Igf2r on the paternal 
chromosome.  
 
Further, I set up a cell culture system to investigate the stability of lncRNAs. Half-
life is one of the parameters to define the function of lncRNAs (Guenzl and 
Barlow 2012). A long half-life implies a role for the transcript product, whereas a 
short half-life is an indication that transcription is the biological relevant 
mechanism. In combination with Next Generation RNA Sequencing, this system 
will allow genome wide characterization of lncRNA stability.  
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2. Introduction 
 
2.1 Genomic imprinting 
 
2.1.1 Definition 
 
Genomic imprinting is an epigenetic phenomenon so far only observed in 
mammals, flowering plants and some insect species (Ferguson-Smith 2011). 
It is characterized by silencing of one of the parental copies of a gene in 
diploid cells, resulting in expression of either the maternal or the paternal copy 
of a gene. This effect is independent of the sex of the organism, as an 
imprinted gene is, for example, only expressed from the allele derived from 
the mother in both, male and female offspring. Thus, in contrast to the 
majority of genes that are expressed from both alleles, imprinted genes show 
a parent of origin specific expression. Genomic imprinting (GI) does not 
depend on differences in the DNA sequence of the parental chromosomes, as 
it also occurs in inbred mouse strains who share the identical base sequence 
on both chromosomes (Barlow and Bartolomei 2007). Thus, imprinting relies 
on epigenetic mechanisms. Epigenetics is defined as mitotically heritable 
modifications that do not depend on changes in the DNA sequence. 
 
Proper expression of imprinted genes is essential for normal embryonic 
development. Experiments in mice using nuclear transfer showed that both 
parental chromosomes are required. Embryos with two paternal 
chromosomes (androgenic) showed normal trophoblast but poor inner cell 
mass development whereas embryos with two maternal chromosomes 
(gynogenic) showed a reciprocal pattern (Barton, Surani et al. 1984; McGrath 
and Solter 1984; Surani, Barton et al. 1984). These results demonstrated why 
parthenogenesis does not occur in mammals and pose the question what the 
difference between the parental genomes is. Differential expression of 
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developmentally important genes could be a plausible explanation. Consistent 
with this hypothesis, imprinted genes were discovered in mammals, and the 
first ones were Igf2r (Barlow, Stoger et al. 1991) and Igf2 (DeChiara, 
Robertson et al. 1991) which respectively act as growth inhibitor and growth 
factor in embryonic development.  
 
2.1.2 The molecular basis of genomic imprinting 
 
An imprint, as an epigenetic mark that controls parent-of-origin specific gene 
expression, must fulfill the following criteria (Ferguson-Smith 2011): 
• Ability to influence transcription  
• Establishment has to take place during gametogenesis, when parental 
chromosomes are spatially separated. 
• Mitotic heritability and resistance to epigenetic reprogramming during 
development in somatic tissues 
• It must be able to be erased during germ line development in the 
primordial germ cells and re-established in a sex-specific manner 
during germ cell maturation.  
 
The only known epigenetic modification that fulfills these criteria is DNA 
methylation (Ferguson-Smith 2011). DNA-Methylation is defined as covalent 
attachment of a methyl group to the C5 atom of cytosine residues. This 
predominantly occurs in the context of 5’CpG3’ dinucleotides. Interestingly 
this dinucleotide is underrepresented in the mammalian genome compared to 
its predicted statistical occurrence (about 20% of the expected frequency 
(Antequera 2003)). One explanation for this discrepancy between observed 
and expected CpG occurrence is that methylated C is spontaneously 
deaminated and converted to thymidine, thus being a hot spot for point 
mutations (Duncan and Miller 1980). Therefore, CpGs in non-conserved 
regions might have been lost during evolution. However, regions that are 
enriched in CpG dinucleotides are mostly protected from methylation. These 
so called CpG islands can be found at about 70% of mammalian promoter 
regions (Deaton and Bird 2011). Generally, only a few CpG islands show 
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DNA-methylation, a modification that is associated with transcriptional gene 
silencing. These methylated CpG islands are mostly found in imprinted 
regions, where some promoters are differentially methylated on the two 
parental chromosomes and on the inactivated X-chromosome in female 
mammals (Wutz and Gribnau 2007). Such differentially methylated regions 
(DMRs) can be distinguished into two classes: 
 
 
1. Gametic DMRs (gDMRs) 
These elements acquire their methylation state already in the germ cells 
before fertilization takes place. Deletion of those regions followed by 
transmission through the germ line lead to a loss of imprinted expression, 
which demonstrates that such DMRs act as an imprint control element (ICE) 
(Stoger, Kubicka et al. 1993; Williamson, Ball et al. 2004; Thorvaldsen and 
Bartolomei 2007). So far ICEs, also called imprint control region (ICR) or 
imprinting center (IC), have been identified for seven imprinted regions 
(Barlow 2011).  
 
2. Somatic or secondary DMRs (sDMRs) 
These elements gain de novo methylation in diploid cells during embryonic 
development and depend on the presence of gDMRs (Lopes, Lewis et al. 
2003). The secondary methylation often occurs in a tissue specific manner 
(Shiota, Kogo et al. 2002; Edwards and Ferguson-Smith 2007). In contrast to 
gDMRs, which are essential for imprinted gene expression, sDMRs occur only 
at few imprinted protein-coding gene promoters and are not essential for 
imprinted gene silencing (Barlow 2011).   
 
Several methyltransferases are involved in DNA methylation: DNMT1 is the 
maintenance DNA methyltransferase (DNMT). It methylates cytosines on 
hemimethylated DNA, which is the form of DNA immediately after DNA 
synthesis, where the old DNA strand is methylated and the new one is 
unmethylated. Thereby DNMT1 ensures mitotic heritability of this epigenetic 
modification. Deletion of DNMT1 lead to loss of imprinted expression in mice, 
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resulting in biallelic silencing of protein-coding genes and biallelic expression 
of lncRNAs (Li, Beard et al. 1993) and thus demonstrated the requirement of 
DNA methylation in genomic imprinting.  
 
DNMT3a and DNMT3b are de novo methyltransferases expressed in the 
male and female germ line. Both interact with the DNA methyltransferase-like 
protein DNMT3L, which has structural similarity but lacks enzymatic activity. 
Several studies demonstrated that DNMT3a and DNMT3L are essential for 
establishing the imprint, whereas loss of DNMT3b had no effect on imprinting 
(Kaneda, Hirasawa et al. 2010). Interestingly, the DNMT3A/3L complex is 
responsible for de novo methylation of gametic DMRs in both female and 
male germ cells. However, at the moment it is not fully understood how the 
same methylation machinery can differentially methylate the DMRs in the 
male and female germ line. Germline-specific transcription of protein-coding 
genes through the DMRs could be a key regulator of de novo methylation, as 
transcription is associated with an open chromatin state which allows DNMTs 
to access their targets. This was demonstrated by truncating the imprinted, 
protein-coding gene Nesp, which lead to a loss of oocyte specific DMR 
methylation in the corresponding Gnas cluster (Chotalia, Smallwood et al. 
2009). Other possible influences involve the DNA sequence itself, epigenetic 
mechanisms like histone modifications or a combination of these factors 
(Ferguson-Smith 2011). For example, Ooi et al. found that DNMTL3L 
recognizes unmethylated lysine4 at histone 3 and thereby mediates de novo 
DNA methylation via DNMT3A2 (Ooi, Qiu et al. 2007), an isoform of DNMT3A 
which lacks the N-terminal 219 amino acids and localizes to open chromatin 
regions (Chen, Ueda et al. 2002).  
 
2.1.3 The imprinting life cycle  
The genomic imprint is established in the germ line. Early in embryonic 
development the germ line is separated from the somatic cell line. Primordial 
germ cells then undergo excessive genome wide de-methylation, thereby 
erasing preexisting imprinting marks. During oogenesis and spermatogenesis, 
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the imprints are re-established in a sex-specific manner. (reviewed in (Li and 
Sasaki 2011)). After fertilization, these gDMRs have to be stably maintained 
during the multiple genome-wide epigenetic reprogramming events that occur 
in the pre-implantation embryo: while the imprint has to be protected from 
demethylation, de novo methylation of the unmethylated allele needs to be 
prevented (Li and Sasaki 2011). In contrast to gDMRs, the sDMRs are absent 
in the germline and are acquired later during post-implantation embryonic 
development succeeding the epigenetic reprogramming that occurs in the 
early embryo (John and Lefebvre 2011). However, both the gDMRs and the 
sDMRs are maintained by DNMT1 in somatic cells during embryonic 
development and throughout the lifetime of the individual.  
 
2.1.4 Why are genes imprinted? 
 
Although genomic imprinting (GI) has now been studied for decades and 
serves as a powerful epigenetic model, the question why imprinting evolved is 
not conclusively answered. GI evolved independently in plants and animals 
(Ferguson-Smith 2011), thus different influences may have led to its 
establishment. A striking question is also why imprinting is only found in 
mammals but not in other vertebrates. To answer this, several models were 
proposed to explain the origin of GI. Here I focus on the two main models, 
which are based on the features of the mammalian reproductive system, 
where embryonic development inevitably depends on the body of the mother.   
 
2.1.4.1 Trophoblast defense theory  
This theory, also called “ovarian time bomb hypothesis” (Varmuza and Mann 
1994; Weisstein, Feldman et al. 2002) proposes that imprinting developed as 
a defense mechanism against ovarian trophoblastic disease. The trophoblast 
is the outer cell layer of a blastocyst (the mammalian pre-implantation 
embryo) and invades the uterine epithelium of the mother to form the 
placenta. This process occasionally leads to tumor formation; however, in 
most cases the tumor is benign. In contrast, spontaneous activation of an 
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unfertilized oocyte in the ovaries could lead to malignant trophoblast formation 
and cancer formation. The trophoblast defense theory states that inactivation 
of the maternal copy of a growth factor gene in early embryonic development 
significantly reduces the risk to develop the disease, as does upregulation of 
growth inhibitors. Thus, an imprinted allele would spread rapidly in the 
population because it provides a selective advantage against this disease.  
 
2.1.4.2 Parental conflict hypothesis  
This hypothesis (Moore and Haig 1991) is based on the fact that in many 
mammals a mother can give birth to offspring from different fathers. In this 
situation, the parental genomes have different interests in the distribution of 
resources to their offspring. The interest of the mother is to produce as many 
viable offspring as possible. As all of them carry her genome, she distributes 
her resources equally to all of them. Additionally she has to ensure that 
enough resources are left for her own survival. Thus, the mother is interested 
in limiting the growth of the embryos. In contrast, the interest of the father is to 
maximize all available maternal resources for only his own offspring alone, 
and therefore to increase embryonic growth.  
 
Consistent with both models described above, several paternally expressed 
genes like Igf2 act as growth factors, while several maternally expressed 
genes like Igf2r act as growth repressors. However, not all genes that show 
imprinted expression fit into these models. For instance the Mash2 gene 
(required for placenta development) is transcribed from the maternal allele but 
silent on the paternal allele (Iwasa 1998).  
 
2.1.5 Imprinted genes are organized in clusters 
 
The majority (>80%) of known imprinted genes are organized in clusters with 
other imprinted and non-imprinted genes (Barlow 2011). Such clusters can be 
several 100kb in size and typically contain between 3 and 10 genes. In most 
cases, one of the genes is a non-coding RNA gene. Clustering indicates that 
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imprinting is not limited to a single gene but that multiple genes are organized 
in one regulatory unit. Mostly, the protein coding genes are expressed from 
one chromosome and the ncRNA from the other chromosome. Expression is 
regulated by the imprint control element in a way that the ncRNA is expressed 
only from the chromosome with the unmethylated ICE. Given the fact that 
many ncRNAs in imprinted cluster silence protein coding genes, methylation 
of the ICE can be referred to as a double negative mechanism (“repressing a 
repressor” (Koerner, Pauler et al. 2009)). 
 
2.1.6 Genomic imprinting can be evolutionary conserved 
 
Genomic imprinting is in many cases conserved between human and mouse 
(Ferguson-Smith 2011) and some imprinting defects are also linked to human 
disease. Well known examples are the Prader-Willi syndrome (PWS) and 
Angelman syndrome (AS). PWS is characterized by a variety of clinical 
features, including short stature, low muscle tone, hyperphagia, obesity, mild 
mental retardation and behavioral disorders. The phenotype of AS includes 
developmental delay, mental retardation, speech impairment, movement 
ataxia, aggressive behavior and excessive laughter (Nicholls and Knepper 
2001). Despite their distinct characteristics, both syndromes are related to 
cytogenetic deletions on human chromosome 15q11-q13 (Knoll, Nicholls et al. 
1989). While PWS arises from a functional loss of the paternal copy of this 
region, AS is caused by the loss of the maternal allele. Further research 
revealed that 15q11-q13 includes a 2Mb imprinted cluster that contains 
several protein coding genes (including the well characterized SNRPN-
SNURF and NDN genes) and small nucloeolar RNA (snoRNA) genes, which 
are exclusively expressed from the paternal allele. The Ube3a (Ubiquitin-
protein ligase E3A) gene, in contrast, was found to be expressed biallelically 
in most somatic tissues, but shows imprinted maternal expression in neurons. 
Thus, a loss of the maternal copy of this gene explains the neurological 
phenotypes observed in AS. The majority of PWS/AS cases is caused by de 
novo deletions or uniparental disomies, however about 5% result from 
imprinting defects or microdeletions of the imprinting center (Nicholls and 
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Knepper 2001). The finding that the PWS/AS region is conserved and also 
found on mouse chromosome 7C lead to development of mouse models to 
further investigate the mechanisms of genomic imprinting within the PWS/AS 
region. For example, it was recently shown in a murine ES cell differentiation 
model, that paternal Ube3a is repressed by an antisense transcript (Meng, 
Person et al. 2012).  
 
The Igf2r cluster (described in detail in section 2.2) is also conserved between 
mouse and human. However, in contrast to its murine ortholog, the human 
IGF2R normally shows non-imprinted biallelic expression  (Kalscheuer, 
Mariman et al. 1993). Despite the fact that both species carry a methylation 
imprint on the maternal allele, imprinted IGF2R expression was only found in 
a minority of tested samples in some embryonic tissues, in Wilms’ tumors and 
in about 40% of tested human placental samples (Yotova, Vlatkovic et al. 
2008). As IGF2R shows imprinted expression in some but not in all tissue 
samples, IGF2R imprinting is referred to as “polymorphic” (Monk, Arnaud et 
al. 2006). In mice, imprinted Igf2r expression correlates with the expression of 
an antisense lncRNA named Airn from the paternal allele (see section 2.2.2). 
In contrast, humans normally do not express a homologous AIRN non-coding 
RNA in the IGF2R cluster, although an active promoter was detected and 
shown to be functional by transgenic experiments. However, the AIRN 
transcript was found in some Wilms’ tumors, albeit a causal connection of 
AIRN expression and imprinted IGF2R expression was not apparent (Yotova, 
Vlatkovic et al. 2008).  
 
2.2 The Igf2r cluster 
 
2.2.1 General features 
 
Igf2r, which is identical with the cation-independent mannose-6-phosphate 
receptor, codes for a trans-membrane receptor which functions to attenuate 
insulin like growth factor 2 (Igf2) signaling during development. Thereby Igf2r 
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acts as a negative regulator of embryonic growth, which is required for normal 
development. The loss of a functional Igf2r leads to fetal overgrowth and 
abnormal heart development and results in neonatal lethality (Lau, Stewart et 
al. 1994; Wang, Fung et al. 1994). 
 
The region containing Igf2r is absent in two naturally occurring deletions on 
chromosome 17:  
-) Thp (T hairpin) is a 4cM deletion that also includes the brachyury (T) and 
the Tme (T-associated maternal effect) locus. The name T hairpin refers to 
the phenotype of a kinky tail.  
-) tlub2 covers 0.5cM and overlaps with the Thp region. This deletion does not 
contain brachyury, but like Thp also includes the Tme locus.  
Deletion of the Tme region was found to be embryonic lethal at E.15, only 
when the mutation is inherited from the mother. In 1991, Barlow et al. found 
that Igf2r maps to this locus and is expressed only from the maternal allele 
(Barlow, Stoger et al. 1991). 
 
Igf2r is one of the six protein-coding genes in a 500kb cluster on distal mouse 
chromosome 17 (Fig. 1). The Plg, Mas1 and Slc22a1 genes are not 
expressed in a parent of origin dependent manner but show biallelic 
expression. The other protein-coding genes are paternally silenced and 
maternally expressed at least in some tissues; Slc22a2 and Slc22a3 are 
expressed biallelically in some adult tissues but show imprinted, maternal 
specific expression in extra embryonic lineages like placenta (Zwart, Sleutels 
et al. 2001) and visceral yolk sac and are therefore referred to as EXEL 
(extra-embryonic lineage) specific imprinted genes (Hudson, Seidl et al. 
2011). However, the placenta is a complex organ, which additionally is subject 
to contamination with maternal tissue. To obtain an improved model for 
studying extra-embryonic lineage (EXEL) imprinted expression, Hudson et al. 
used the endoderm layer of the visceral yolk sac (VYS), which comprises a 
pure population of cells. In contrast to the EXEL imprinted genes, Igf2r is 
expressed maternally in most embryonic and adult tissues and is therefore 
referred to as a multi lineage (ML) imprinted gene. In addition to the protein 
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coding genes, the Igf2r cluster also contains a paternally expressed long non-
coding RNA named Airn (described in detail in section 2.2.2). 
 
 
 
 
Figure 1. The Igf2r cluster on mouse chromosome 17 
The maternal allele is shown on top, the paternal allele on bottom. Biallelically expressed 
genes are shown as black box, maternally expressed genes as red box and silent genes as 
white box. Arrows indicate the direction of transcription. The macro lncRNA Airn is depicted 
as blue wavy line. ICE: imprint control element. Black diamond: methylated ICE. White 
diamond; unmethylated ICE. 
 
 
 
The Igf2r cluster contains 2 differentially methylated regions (DMRs): 
DMR1 is a CpG island that contains the Igf2r promoter and serves as the 
somatic DMR. DMR2 is a CpG island located in intron2 of Igf2r and includes 
the Airn promoter CpG island. DMR2 carries a maternal methylation imprint 
set in the oocyte and was identified as the imprint control element (ICE, see 
Fig.1) of the cluster, as deletion of this region lead to loss of imprinted 
expression (Wutz, Smrzka et al. 1997).  
 
2.2.2 The Igf2r cluster contains the macro non-protein coding RNA Airn 
 
In addition to the protein coding genes, the cluster also contains an unusual 
non-coding transcript named Airn (antisense-Igf2r-RNA-non-coding). It is a 
118kb transcript that overlaps with the 5’ end of Igf2r in antisense orientation. 
Airn also overlaps with Mas1, as its 3‘ end lies within intron 8 of this gene 
(Lyle, Watanabe et al. 2000). The transcriptional start site (TSS) of Airn is 
located in the ICE. As this region carries the methylation imprint on the 
Plg Slc22a3 Slc22a2 Slc22a1 Igf2r Mas1 ICE 
Airn 
Plg Slc22a3 Slc22a2 Slc22a1 Igf2r Mas1 ICE 
mat 
pat 
  17 
maternal allele, Airn is expressed exclusively from the unmethylated paternal 
allele in most embryonic and adult tissues. In contrast, Airn is not expressed 
in undifferentiated ES cells, which correlates with the finding that the Airn 
promoter carries a repressive histone modification (H3K27me3) at this stage, 
which is lost after 5 days of in vitro ES cell differentiation (Latos, Stricker et al. 
2009). Airn is a macro lncRNA (long non-coding RNA), a class of inefficiently 
spliced, nuclear localized lncRNAs whose function does not depend on 
processing into small RNAs (Guenzl and Barlow 2012). The unspliced 118kb 
Airn transcript has a relatively short half-life of approx. 90 min, compared to 
Igf2r, which has a half-life of about 15h. However, a minority of about 5% of 
nascent Airn transcripts is spliced into one of the four known variants which 
show increased stability and are exported to the cytoplasm (Seidl, Stricker et 
al. 2006). As imprinted gene silencing in the Igf2r cluster was demonstrated to 
act strictly in cis (Sleutels, Zwart et al. 2002), the fact that the spliced 
transcripts are transported away from the site of Igf2r repression opens the 
possibility that the unspliced nuclear localized 118kb transcript might be the 
functional variant of Airn.  
 
2.3 The macro long non-coding RNA Airn silences Igf2r in cis 
 
In 2001, Wutz et al. published a paper about the deletion of the whole DMR2 
(Region 2 Deletion, R2∆) in mice. The R2∆ allele lacks the imprint control 
element and thus the Airn promoter. The authors demonstrated that maternal 
inheritance of R2∆ did not affect the phenotype, as Igf2r was expressed 
maternally, and Airn was expressed form the paternal allele. In contrast, upon 
paternal inheritance no Airn RNA was detected, and paternal Igf2r expression 
was restored, indicating that DMR2 is essential for imprinted expression of 
Igf2r. Additionally, paternal inheritance of the R2∆ allele could rescue the 
maternally lethal Tme deletion, by complementing the lack of maternal Igf2r 
expression by paternal Igf2r expression (Wutz, Theussl et al. 2001). However, 
these experiments could not answer the question if an intact DMR2 or the Airn 
ncRNA product transcribed from DMR2 are responsible for the imprinted 
expression of Igf2r. Using the R2∆ allele for crosses with mice carrying a 
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deletion of the whole Igf2r cluster (Thp-mutation, described in section 2.2.1.), 
Zwart et al. further demonstrated that DMR2 is also required for imprinted 
expression of the Slc22a2 and Slc22a3 genes in placenta (Zwart, Sleutels et 
al. 2001).  
 
Further characterization of DMR2 revealed that the CpG island within DMR 2 
lies downstream of the Airn promoter and contains a stretch of tandem direct 
repeats (TDRs). Koerner et al. generated targeted deletions of both, the TDRs 
and the entire GpG island (CGI) in an in vitro ES cell model and in mice to 
investigate the impact of these elements on genomic imprinting of the Igf2r 
cluster (Koerner, Pauler et al. 2012). Notably, in contrast to R2∆, both 
deletions did not impair the Airn promoter and the transcriptional start site. 
The authors found that paternal inheritance of the 692bp TDR deletion 
(TDR∆) lead to shortening of Airn at the 3’ end to approx. 90 kb. A minor 
reduction in the maternal/paternal ratio of Igf2r expression was observed, 
indicating that loss of the TDRs slightly reduces the silencing ability of Airn. 
Also, like in the wildtype, the paternal ICE remained unmethylated. In 
contrast, when inherited on the maternal allele, deletion of the TDRs in mice 
resulted in almost complete loss of DNA methylation over the maternal ICE. 
Thus the authors conclude that the TDRs play a crucial role in the gain of 
methylation of the maternal ICE. Deletion of the 1129bp CpG island (CGI∆) on 
the paternal chromosome lead to a significant reduction in total Airn RNA 
levels and a reduced length of the transcript. Accordingly, the CGI deletion 
also resulted in de-repression of paternal Igf2r expression. Interestingly, the 
authors found that undifferentiated ES cells carrying the paternal CGI∆ 
showed methylation of the paternal Airn promoter which was maintained 
during 14 days of ES cell differentiation. Thus, a major role for the CGI is to 
protect the paternal ICE from methylation. 
 
In another key experiment in mice, Sleutels et al. generated the Air-T allele by 
truncating Airn to 4% of its length via insertion of a polyA signal downstream 
of the Airn promoter (Sleutels, Zwart et al. 2002). Thereby, the authors aimed 
to test if the presence of an intact DMR2 is sufficient to induce imprinted 
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expression of Igf2r or if the Airn lncRNA product is required. The truncation 
neither affected the correct methylation of the imprint control element (ICE) 
nor the function of the paternal Airn promoter. However, the truncated Airn 
was not able to silence Igf2r, Slc22a2 and Slc22a3 on the paternal allele; thus 
it was demonstrated that Airn is required for in cis silencing (on the same 
chromosome) of all three imprinted protein-coding genes in the cluster. 
 
The next step in elucidating the function of Airn in genomic imprinting was to 
ask which part of Airn is functional. To answer this question, members of the 
Barlow lab generated truncations of Airn from its 3’end before and after its 
overlap with the Igf2r transcription start site (Latos, Pauler et al. manuscript in 
progress) (Fig. 2A), using a previously established in vitro ES cell system 
(described later in section 2.5). Truncations of Airn at 3kb and 16kb resulted 
in a shortened Airn that was not capable to induce imprinted expression of 
Igf2r. In contrast, Airn truncated to 31kb and 51kb overlapped with the Igf2r 
transcription start site (TSS) and imprinted expression was not affected. 
Insertion of the polyA cassette at 27kb, immediately before the Igf2r TSS 
failed to efficiently truncate Airn (Fig. 2A). These results narrowed down the 
functional length of Airn to the fragment between the 16kb and 31kb 
truncation; however the data was not sufficient to state whether Airn functions 
via transcriptional interference or on the basis of the RNA product (these 
models are described in section 2.7). To truncate Airn from the 5’end, its 
promoter was inserted at the 27kb site immediately before the Igf2r promoter 
in +/R2∆ ES cells, thereby creating the AirnPmove alleles FAP (forward Airn 
promoter) and RAP (reverse Airn promoter), schematically shown in Fig. 2B.  
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Figure 2. Genetic manipulations to determine the functional length of Airn 
(A) Diagram of the Airn expressing region in the Igf2r cluster. Exons are shown as vertical 
lines/boxes. Arrows represent expressed protein-coding transcripts. Red: Igf2r, black: Mas1, 
grey box: the silent Au76 pseudogene. Wavy lines: Airn lncRNA transcript. Blue: wt Airn and 
3’truncations, pink: 5’ truncated Airn. The dotted line for 27kb Airn indicates leaky 
transcription through the stop signal. (B) Schematic representation of the Igf2r and Airn 
promoters in AirnPmove alleles. Arrows represent the Airn (grey) and Igf2r (black) promoters, 
arrowhead indicates the transcriptional orientation. The Airn promoter is methylated (black 
lollipop) on the maternal allele in both cell lines. The paternal Igf2r promoter contains a MluI 
restriction site. Note that this figure is not to scale. Cell lines are described in detail in the text.  
 
 
The FAP allele contains the Airn promoter in the same orientation as the 
wildtype  (antisense to the Igf2r promoter), whereas the RAP allele contains 
the promoter in the opposite transcriptional orientation and serves as a control 
for a negative positional effect of the insertion. In contrast to the insertion of 
the polyA cassette at the 27kb site, no position effect was observed in FAP 
and RAP cells lines. These cell lines were also used for in vitro differentiation 
and showed that the shortened Airn expressed from the FAP allele is able to 
silence Igf2r (Latos, Pauler et al. manuscript in progress). 
(A)
(B)
endogenous wt Airn
3kb Airn
16 kb Airn
27 kb Airn
31kb Airn
51kb Airn
AirnPmove
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2.4 Other long non-coding RNAs in imprinted gene clusters 
 
Besides Airn, three other lncRNAs in imprinted gene clusters were tested for 
their gene silencing function.  
2.4.1 Kcnq1ot1  
Mouse chromosome 17 contains the 850kb imprinted Kcnq1 cluster, named 
after the gene for the potassium voltage-gated channel, KQT-like subfamily, 
member 1 (Kcnq1). The cluster consists of several maternally expressed and 
biallelically expressed genes. Within intron 10 of the Kcnq1 gene lies a DMR 
which acts as an imprint control element (ICE). The maternal ICE carries a 
methylation imprint, whereas the unmethylated paternal ICE contains an 
active promoter for the Kcnq1 overlapping transcript 1 (Kcnq1ot1). Kcnq1ot1 
is an approx. 91kb RNA polymerase II (RNAPII) transcript, which is unspliced, 
nuclear localized and has a half-life of 3.5 hours (tested in NIH3T3 cells) 
(Pandey, Mondal et al. 2008). In contrast to Airn, no splice variants are 
known. To test the function of Kcnq1ot1 in establishing imprinted expression, 
it was truncated to 1.5kb by inserting a polyA-cassette. Maternal inheritance 
of this truncation did neither affect the methylation imprint nor the expression 
of imprinted genes in the cluster. In contrast, the paternally inherited 
truncation lead to re-expression of genes which are normally repressed on the 
paternal allele. Thus it was demonstrated that full length Kcnq1ot1 RNA it is 
required for the imprinted expression of protein coding genes within the 
cluster (Mancini-Dinardo, Steele et al. 2006). Additionally, it was shown by 
RNA immunoprecipitation that Kcnq1ot1 interacts with chromatin modifiers 
like the histone methyltransferase G9a and the polycomb group proteins 
SUZ12 and EZH2 (Kanduri 2011). Further, Kcnq1ot1 directly interacts with 
DNMT1, thereby regulating methylation of somatic DMRs (Mohammad, 
Mondal et al. 2010). Heterozygous inheritance of a non-functional DNMT1 
mutant lead to biallelic expression of Kcnq1ot1 in embryos but not in placenta 
(Weaver, Sarkisian et al. 2010). Taken together, these findings indicate that 
gene silencing by Kcnq1ot1 is a multilayer process, which involves DNA 
methylation, lncRNA transcription and the recruitment of repressive chromatin 
modifications.  
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2.4.2 Nespas 
 
The 110kb Gnas (Guanine nucleotide binding protein, alpha-stimulating) 
cluster is located on mouse chromosome 2 (reviewed in (Barlow 2011)). It has 
a complex organization and codes for multiple transcripts, which are either 
maternally, paternally or biallelically expressed. Within the same 
transcriptional orientation lie promoters for four genes: the maternally 
expressed Nesp (neuroendocrine secretory protein), the paternally expressed 
Gnasxl, the paternally expressed non-coding Ex1a gene and Gnas, which is 
expressed biallelically in most tissues. These genes use alternative first 
exons, but all are spliced to exon 2 of the Gnas gene and share several of the 
Gnas downstream exons. In the opposite transcriptional orientation, 2.4kb 
upstream of the Gnasxl TSS, lies the promoter for a paternally expressed 
ncRNA (Peters and Williamson 2007). This 14kb transcript overlaps with the 
Nesp gene in antisense orientation and therefore is called Nesp antisense 
(Nespas) (Wroe, Kelsey et al. 2000). Its promoter lies within a DMR that also 
contains the Gnasxl promoter. This DMR was identified as the imprint control 
element, by deletion of a 1.6kb region covering the Nespas promoter. Upon 
paternal inheritance, this manipulation led not only to a loss of Nespas, but 
also to de-repression of Nesp on the paternal allele. Additionally, Gnasxl 
expression was reduced, maybe because the 1.6kb deletion also eliminates a 
putative regulatory element of Gnasxl (Peters and Williamson 2007). Nespas 
was recently demonstrated to be required for imprinted expression of Nesp by 
generating a lowly expressed Nespas mutant (Nespas hypomorph). Upon 
maternal inheritance, the hypomorph was able to down-regulate Nesp in the 
absence of gDMR methylation. Thereby the authors demonstrated that 
expression of Nesp is sufficient to down-regulate Nesp expression. 
(Williamson, Ball et al. 2011). However it is currently not known if Nespas also 
influences imprinted expression of non-overlapped genes within the Gnas 
cluster. 
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2.4.3 H19 
 
The 191kb Igf2 cluster is located on distal mouse chromosome 7 and contains 
the two paternally expressed protein coding genes Insulin-2 (Ins2) and Igf2 
and the maternally expressed ncRNA H19 (fetal hepatic cDNA clone 19). It 
was first identified as a cDNA clone in a screening to find specific mRNAs in 
fetal liver. It was further characterized as a cytoplasmic localized RNAPII 
transcript that, like mRNAs, is spliced and polyadenylated, but is not 
translated into protein. These features, together with the finding that murine 
and human H19 share 77% sequence identity but lack conservation of open 
reading frames (ORFs), led to the hypothesis that H19 might function on the 
level of RNA (Brannan, Dees et al. 1990). Overexpression of H19 was 
demonstrated to be lethal by embryonic day 14-15, indicating the importance 
of dosage regulation for this gene. (Brunkow and Tilghman 1991). In 1991, 
Bartolomei et al. showed that H19 is expressed only from the maternal allele 
and mapped to the same imprinted region of mouse chromosome 7 that 
contains the paternally expressed Igf2 gene (Bartolomei, Zemel et al. 1991). 
The two genes were shown to be physically linked (Zemel, Bartolomei et al. 
1992) and to share the same downstream enhancers (Leighton, Saam et al. 
1995). Upstream of the H19 promoter lies a 2kb differentially methylated 
domain (DMD). Deletion of this domain lead to loss of imprinted expression 
and thus identified the DMD as the imprint control element of the cluster 
(Thorvaldsen, Duran et al. 1998).  
 
The finding that the H19 DMD contains a region which can block access to 
enhancers (Bell and Felsenfeld 2000) lead to the “boundary model” for 
imprinted expression in the cluster: the unmethylated DMD on the maternal 
allele is able to bind multiple copies of the zinc finger protein CTCF (CCCTC-
binding factor). CTCF bound to this domain is thought to influence chromatin 
topology and act as a boundary which blocks interaction of the Igf2 promoter 
with the downstream enhancers. This allows interaction of the enhancers with 
the H19 promoter, resulting in H19 expression from the maternal allele. On 
the paternal allele the DMD is methylated which inhibits CTCF binding; 
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therefore the enhancers are accessible to Igf2, resulting in Igf2 expression. 
Additionally, the methylated DMD acts as a repressor for H19. (Reviewed in 
(Arney 2003)). 
 
The model described above indicates that, in contrast to Airn and Kcnq1ot1, 
H19 has no cis function in gene silencing. This was demonstrated by 
replacing the H19 gene with a protein-coding gene, which had no effect on 
DNA methylation or imprinted expression of Igf2 (Jones, Levorse et al. 1998). 
Additional evidence for this model was provided by a full deletion of the H19 
promoter (Schmidt, Levorse et al. 1999). Upon paternal inheritance the 
deletion did not affect imprinted expression of Igf2 and H19, and no change in 
DNA methylation was observed. Maternal inheritance of the H19 deletion had 
no effect on Igf2 levels in neonatal liver and showed the same DNA 
methylation pattern as in the wildtype. Based on these results, neither H19 
transcription nor the H19 RNA product are required for the onset or 
maintenance of imprinted Igf2 expression, thus a cis silencing role for the H19 
RNA is unlikely. Instead H19 was reported to regulate imprinted genes in 
trans, as it is the host transcript of the micro RNA miR-675 (Gabory, Ripoche 
et al. 2009).  
 
2.5 An in vitro ES cell differentiation system as a model  
 
As many imprinted genes are involved in embryonic development, most 
studies used targeted gene mutations in in vivo models. However, generation 
of mutant mice is an elaborate and time-consuming procedure. Thus, having a 
cell culture system to study processes involved in genomic imprinting would 
be extremely useful. It was shown that cultured embryonic stem (ES) cells, 
which are derived from the pluripotent inner cell mass of blastocyst stage 
embryos, can be used ex vivo to successfully recapitulate the process of X-
chromosome inactivation, an epigenetic process used in female mammals to 
silence one of the two copies of this chromosomes (Wutz 2007). Upon in vitro 
differentiation, in female ES cells one of the X-chromosomes is inactivated 
like in the in vivo situation in a correct spatial and temporal manner. As X-
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inactivation and imprinting shares many features like expression of non-
coding RNAs, DNA-methylation and alteration of histone modifications, ES 
cells were also postulated to act as a possible model to study imprinting 
(Braidotti, Baubec et al. 2004). In 2009, Latos et al. demonstrated that ES 
cells can indeed be used to study the processes involved in the onset of 
imprinted expression of Igf2r (Latos, Stricker et al. 2009). The authors used 
two independent inbred ES cell lines (CCE and D3) for in vitro differentiation 
upon LIF withdrawal and retinoic acid treatment.  
 
First, Latos et al. observed the dynamics of gene expression of a stem cell 
marker (Oct4) and two differentiation markers (Gata4, Fgf5) during five days 
of in vitro differentiation. This analysis allowed them to define the time window 
for expression of differentiation markers between day2 to day3, the same time 
in which they also observed a significant increase in Airn expression. The 
authors confirmed that Igf2r was already expressed at low level in 
undifferentiated ES cells, but interestingly found that Igf2r is greatly 
upregulated between day2 and day4 of in vitro ES cell differentiation. To 
obtain allele specific information, the authors created an ES cell line with a 
single nucleotide polymorphism (SNP) in exon 12 of Igf2r. By using an allele 
specific qPCR assay, the authors demonstrated that during 14 days of 
differentiation, maternal Igf2r is enriched 10-fold over paternal Igf2r. Taken 
together, these observations lead to the conclusion that Airn expression does 
not completely silence Igf2r, but instead prevents upregulation of paternal 
Igf2r. Further, the authors investigated the changes in methylation status and 
the presence of active and repressive histone modifications in the 
differentiating ES cells. They found that upon differentiation, the paternal Igf2r 
promoter gains methylation, which was also observed in embryonic 
development (Stoger, Kubicka et al. 1993). Additionally the Igf2r promoter 
gained the repressive H3K9me3 mark in differentiating ES cells, which was 
previously reported to correlate with the presence of DNA methylation 
(Regha, Sloane et al. 2007). In summary, it was demonstrated that in vitro ES 
cell differentiation serves as a reliable model, which successfully mimics the 
onset of Igf2r imprinted expression in mice.  
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2.6 Stability of long non-coding RNAs 
 
To characterize the increasing number of known lncRNAs, Guenzl et al. 
proposed the introduction of a “functionality index”, based on various easily 
detectable features (Guenzl and Barlow 2012). One of these features is 
lncRNA half-life. A long half-life implies a role for the transcript itself, whereas 
a short half-life is an indication that transcription of the RNA is the relevant 
biological mechanism. RNA-stability can be assayed by blocking transcription 
and comparing RNA levels to untreated controls after defined lengths of 
treatment. A commonly used reagent is Actinomycin D (ActD), an organic 
molecule secreted by some species of gram-positive actinobacteria. It 
intercalates into DNA at guanine nucleotides, especially in GC rich regions. 
Thereby it interferes with DNA replication and blocks transcriptional 
elongation by RNAPII. In biological research, ActD is mainly used in cell 
culture experiments, where it acts as transcriptional inhibitor to assay half-
lives of mRNA (Ross 1995). Like mRNAs, the Airn, Kcnq1ot1 and H19 
lncRNAs are transcribed by RNAPII, which allows to compare the data from 
ActD experiments to mRNA stability. However, it has been reported that 
lncRNAs display a structurally diverse class of RNAs which are either 
transcribed by RNAPII or RNA polymerase III (RNAPIII) (Amaral, Clark et al. 
2011). 
 
A recent study used Actinomycin D treatment of N2a cells in a micro array 
based genome wide assay for both mRNA and lncRNA stability. The authors 
found that lncRNAs are not generally unstable, but like mRNAs show half-
lives ranging between less than 30 min to over 48 hours. However, lncRNAs 
showed reduced stability compared to mRNAs and were enriched in 
transcripts with a half-lives of less than 2 hours. Additionally, nuclear localized 
lncRNAs were generally less stable, as 52% of these transcripts had a half-life 
shorter than 2 hours (Clark, Johnston et al. 2012). This finding is consistent 
with the hypothesis that nuclear localized lncRNAs are generally short-lived, 
which implicates a regulatory function as a high turnover rate allows a fast 
response to environmental stimuli.  
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2.7. Models for gene silencing by macro ncRNAs 
 
The fact that macro lncRNAs like Airn and Kcnq1ot1 are unstable transcripts 
lead to the question whether cis gene silencing by macro non-coding RNAs 
functions at the level of transcription or the RNA product. Several models for 
the action of ncRNAs in imprinted gene silencing were published (Pauler, 
Koerner et al. 2007), two of which I want to explain here in more detail.  
 
2.7.1 Transcriptional interference (TI)  
In this model, the ncRNA product itself has no role in gene silencing; instead it 
is based on the hypothesis, that transcription through the promoter region of a 
gene interferes with initiation from this promoter and thereby silences the 
corresponding gene. TI is a known mechanism in organisms with compact 
genomes like bacteria and yeast (Shearwin, Callen et al. 2005; Gullerova and 
Proudfoot 2010) but was also suggested for mammalian genes like N-ras 
which is downregulated by the unr transcript in mice (Boussadia, Amiot et al. 
1997). As imprinted macro lncRNAs like Airn also overlap with protein coding 
genes, TI is a possible mode of action for imprinted gene silencing. However, 
transcriptional overlap cannot explain transcription-based silencing or 
activation of other genes in the same cluster which do not overlap with the 
interfering transcript, a situation for example observed for the Slc22a2 and 
Slc22a3 genes in the Igf2r cluster. Instead, transcription could interfere with 
cis regulatory elements and thereby indirectly lead to transcriptional silencing 
of non-overlapping genes. Three possible modes of action were proposed 
(Pauler, Koerner et al. 2007): Transcription displaces a DNA binding protein 
which normally acts as a transcriptional activator for multiple genes in the 
cluster. Thus the affected genes cannot be activated and are not expressed. 
Alternatively, the process of transcription could activate a binding site for a 
silencing protein, which actively blocks transcription of the affected gens. The 
third possibility is that transcription activates a binding site for an insulator 
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protein, which in turn blocks access of a downstream activator to the 
promoters of the silenced genes.  
 
2.7.2 ncRNA directed targeting  
 
In this model, the ncRNA product recruits repressive chromatin marks to 
silence flanking genes in the cluster. It is based on a common model for X 
chromosome inactivation, where the inactive X-chromosome is coated with 
the in cis expressed Xist (X-inactive specific transcript) ncRNA. This process 
is followed by a gain of repressive histone marks and DNA hypermethyation 
over the whole chromosome. Some lncRNAs in imprinted clusters show 
similar effects which are, however, restricted to genes within the cluster and 
do not spread over the whole chromosome.  For example, studies in placenta 
revealed that macro lncRNAs like Airn and Kcnq1ot1 also interact with 
proteins involved in heterochromatin formation, for example PRC2 (polycomb 
repressive complex 2) or the histonemethyltransferase G9a (Nagano, Mitchell 
et al. 2008; Umlauf, Fraser et al. 2008). G9a mainly catalyzes dimethylation of 
lysine9 on histone3 (H3K9me2) (Tachibana, Sugimoto et al. 2002), but is also 
capable to catalyze tri-methylation (H3K9me3) (Yokochi, Poduch et al. 2009), 
which correlates with gene silencing. Knock out experiments showed that G9a 
is required for the imprinted expression of Slc22a3, as a loss of G9a resulted 
in biallelic expression of Slc22a3 (Nagano, Mitchell et al. 2008). In the 
wildtype placenta, Airn accumulates at the Slc22a3 promoter and it was 
proposed that Airn recruits G9a, which mediates the acquisition of the 
repressive H3K9me3 chromatin mark and induces gene silencing. However, 
in placenta carrying a paternal Air-T allele, a ChIP assay revealed that G9a 
does not accumulate over the Slc22a3 promoter when Airn is truncated to 4% 
of its length (Nagano, Mitchell et al. 2008). Taken together, these data 
indicate a role for the full length Airn lncRNA product in EXEL imprinted gene 
expression.  
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2.8 Aim of the project 
 
My first aim was to characterize the Igf2r promoter region chromatin in 
differentiating +/FAP ES cells. Thereby I aimed to obtain information on which 
of the models introduced in section 2.7 is preferable for the gene silencing 
function of Airn. Contrary to expectation, the Igf2r promoter DMR did not gain 
secondary methylation in differentiating +/FAP cells, nevertheless Igf2r 
showed imprinted expression. It has been previously reported in a murine 
fibroblast system, that methylation of the paternal Igf2r promoter correlates 
with the presence of repressive histone modifications like H3K9me3. (Regha 
et al. 2007). The same chromatin mark was also found over the Igf2r promoter 
in differentiating ES cells (Latos, Stricker et al. 2009). The lack of a somatic 
DNA methylation at the paternal Igf2r promoter opened the field for testing the 
hypothesis that heterochromatinization is not necessary for silencing Igf2r, a 
model which could not be tested with the other cell lines used before.   
 
I started my project by investigating promoter methylation in day5 
differentiated +/FAP, +/RAP and R2∆ ES cells, which recapitulated the 
findings mentioned before. Then I investigated the expression of Igf2r, using 
standard PCR and quantitative Sanger sequencing. The presence of a SNP in 
the paternal allele allowed me to observe allele specific expression. I further 
set up the conditions for using in vitro crosslinked differentiated ES cells in 
ChIP (chromatin immunoprecipitation) experiments and tested for an active 
chromatin mark. In my results, I present data which show that the Igf2r 
promoter contains active chromatin marks on both, the maternal and the 
paternal allele in +/FAP cell lines in three independent biological replicates 
despite full imprinted expression in these cells. Additionally, I set up a system 
to investigate stability of long non-coding RNAs based on Actinomycin D 
treatment, which will also allow to examine RNA stability on a genome wide 
basis using the RNA sequencing pipeline established in the Barlow lab 
(Huang, Jaritz et al. 2011). 
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3. Results 
 
Part I: Features of a promoter silenced by a macro 
lncRNA 
 
The Igf2r promoter was shown to be epigenetically silenced by the macro 
lncRNA in vivo and in ex vivo cell culture models. In my thesis I aimed to 
characterize the Igf2r promoter in the three different ES cell lines introduced in 
section 2.3. (see Fig. 2B). The R2Δ/+ cell line which lacks DMR2 (and thus 
the Airn promoter) on the maternal allele and has a paternal wt (+) allele, and 
the two cell lines with the paternal Airn promoter move, +/FAP and +/RAP. 
(Note that by convention, the maternal allele is always written on the left and 
the paternal on the right.). Here, I used an ex-vivo ES cell differentiation 
system introduced by Latos et al. (Latos, Stricker et al. 2009).  
 
3.1. Genotyping  
 
To test the genotype of the ES cell lines, I used genomic DNA from the 
differentiated ES cell for a genotyping assay. The method is based on a 
restriction length polymorphism, which allows to distinguish between the 
parental alleles. Given the fact that the DMR2 (containing the Airn promoter) 
is exclusively methylated on the maternal allele (Stoger, Kubicka et al. 1993), 
restriction with a methylation sensitive enzyme will give fragments of different 
size for the maternal and the paternal allele. The restriction fragments can be 
analyzed by a southern blotting strategy based on the methylation state of 
DMR2 in the used ES cell lines. Here I used the enzymes BglII and the 
methyl-sensitive MluI. BglII recognizes the sequence 5'-AGATCT-3' and MluI 
recognizes 5’-ACGCGT-3'. Note that the MluI recognition sequence contains 
two CpG dinucleotides that block cutting when they are methylated. As the 
MluI site lies within DMR2, restriction with this enzyme can be used to 
distinguish between the maternal and paternal allele based on the parental 
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specific methylation state. This strategy (graphically summarized in Fig. 3A) 
allowed me to distinguish between the R2∆/+ cell line and the AirnPmove cell 
lines. However, it is not able to distinguish between +/FAP and +/RAP cells. 
Southern blotting results are shown in Fig. 3B for two independent biological 
replicates.  
 
 
Figure 3. Genotyping for R2∆/+ and AirnPmove ES cells 
(A) Schematic representation of the Airn promoter and the expected restriction fragments in 
R2∆ and AirnPmove ES cells. Top: R2∆/+ Bottom: +/FAP and +/RAP cells. AirnP: wt Airn 
promoter. Δ: deletion of the Airn promoter. BglII, MluI: restriction sites for these enzymes. 
Empty lollipop: unmethylated DMR2. Black lollipop: methylated DMR2(=imprint) Southern blot 
hybridization probe OT2.4 is shown as green bar.  
(B) Southern blots of genomic DNA from the indicated cell lines, digested with restriction 
enzymes (B: BglII, BM BglII + MluI). Two independent biological replicates are shown (dif10, 
dif11). UM: unmethylated allele. M: methylated allele. Δ: allele containing the Airn promoter 
deletion. ND: not done 
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For BglII restriction I observed a band at 6.0kb for the allele that carries the 
R2Δ deletion and a 9.7kb band for the allele carrying the wt Airn promoter 
(Fig. 3B). For BglII and MluI digest I observed an additional 8.2kb band in 
R2Δ/+ cells, which corresponds to the unmethylated paternal Airn promoter 
where MluI is able to cut. In contrast, I did not see this band in +/FAP and 
+/RAP cells where the maternal Airn promoter is methylated and thus MluI 
does not cut. 
 
 
3.2 Analysis of allele-specific gene expression 
 
With this experiment I aimed to obtain information about the allelic expression 
of Igf2r in +/FAP and +/RAP ES cells after 5 days of differentiation. I used 
cDNA from day5 differentiated +/FAP and +/RAP ES cells and amplified a 
506bp fragment that contains the SNP in exon 1 of Igf2r (Primer pair Igf2r-
MluI-seq was used, see materials and methods). The PCR products were 
purified and sequenced with internal primers. Sequencing results are shown 
in Figure 4. The ACGCG(T/C) shows that the correct sequence was identified. 
I found in three independent biological replicates that in differentiated +/FAP 
cells Igf2r is almost exclusively expressed from the maternal allele. This can 
be seen by a considerable enrichment of the paternal (‘T’) SNP over the 
maternal (‘C’) SNP in the sequencing tracks (Fig. 4, left). In +/RAP cells, both 
SNPs were detected by sequencing, indicating biallelic expression of Igf2r. 
However, the maternal allele was enriched over the paternal, as the peak for 
the maternal ‘C’ SNP was about twice the height of the peak for the paternal 
‘T’ SNP in two biological replicates (Fig. 4, right).  
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Figure 4. Allelic expression of Igf2r in day5 differentiated +/FAP and +/RAP ES cells  
Quantitative SNP sequencing of a 506bp RT-PCR product. Three independent biological 
replicates (dif9, dif10, dif11) are shown. The ACGCG(T/C) shows that the sequence was 
correctly identified. The SNP position is highlighted in light blue. +/FAP cells express Igf2r 
almost exclusively from the maternal allele seen by a ‘C’ peak at the SNP position, whereas 
+/RAP cells express Igf2r from both alleles, seen by peaks for both nucleotides at the SNP 
position. ND: not done.  
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3.3 The repressed Igf2r promoter lacks somatic DNA 
methylation in FAP and RAP cells 
 
Here I examined the methylation status of DMR1, which contains the Igf2r 
promoter and exon 1 of Igf2r, in +/FAP and +/RAP cells after 5 days of in vitro 
differentiation. The R2Δ/+ cell line served as a positive control. Similar to the 
genotyping shown in section 3.1, I used a southern blotting strategy (Fig. 5A) 
using two restriction enzymes, one of which is sensitive to DNA methylation. 
Here I used BglII and the methylation-sensitive NotI which recognizes the 
sequence 5'-GCGGCCGC-3'.  
 
Restriction with BglII gave two distinct fragments. A fragment at 9.5kb which 
corresponds to the wt allele and a 11.9kb fragment, which represents the 
AirnPmove alleles, that carry the 2.5kb inserted Airn promoter region. The 
restriction site for NotI lies within the Igf2r promoter region. When this region 
is unmethylated, NotI can cut and gives a 3.9kb fragment. When the Igf2r 
promoter is methylated, NotI cannot cut and therefore the 3.9kb fragment is 
missing on the blots. For the BgllII+NotI digest, the southern blots show a 
single band at 3.9kb in +/FAP and +/RAP cells. Thus the enzyme was able to 
cut on both alleles, indicating that the Igf2r promoter lacks methylation in 
these cell lines. In contrast, the blots for R2Δ /+ show two bands for the 
BglII+NotI digest, one at 3.9kb and one at 9.5kb, which demonstrates that 
NotI did not cut completely, indicating methylation of the Igf2r promoter. 
Interestingly, the 9.5kb band corresponding to the methylated paternal allele 
appears weaker than the 3.9kb band corresponding to the unmethylated 
maternal allele. This indicates that at day5 of in vitro differentiation, 
methylation of Igf2r promoter is not yet complete (Fig 5 B+C). 
 
 
  35 
 
Figure 5. DNA methylation over the Igf2r promoter in differentiated ES cells 
(A) Schematic representation of the Igf2r promoter region in R2∆/+ and AirnPmove ES cells. 
Left: R2∆/+. Right: +FAP and +/RAP cells. BglII, NotI: restriction sites for these enzymes. 
Empty lollipop: unmethylated DMR1. Black lollipop: methylated DMR1. Southern blot 
hybridization probe EN4kb is shown as orange bar. (B) Southern blots of genomic DNA from 
the indicated cell lines, digested with restriction enzymes (B: BglII, BN BglII + NotI). Three 
independent biological replicates are shown (dif9, dif10, dif11). ND: not done. (C) Same as B, 
but adjusted for brightness and contrast. The black dotted frame indicates different 
adjustment levels as for the remaining blot.  
 
B BN B BN B BN
(B) DNA blots Igf2r promoter DMR
BR dif9
11.9 kb
9.5kb
3.9kb
11.9 kb
9.5kb
3.9kb
11.9 kb
9.5kb
3.9kb
BR dif11
BR dif10
R2D/+ +/FAP, +/RAP
(A) blotting strategy for Igf2r promoter DMR
ND
BR dif9
B BN B BN B BN
11.9 kb
9.5kb
3.9kb
11.9 kb
9.5kb
3.9kb
11.9 kb
9.5kb
3.9kb
BR dif11
BR dif10
ND
(C) DNA blots Igf2r promoter DMR (levels adjusted)
BglII BglII NotI 
9.5 kb 
3.9 kb 
EN4kb 
BglII BglII 
Airn P 
NotI 
11.9 kb 
Igf2r P 
Igf2r P 
EN4kb 
Mat (wt) 
Pat (AirnPmove) 
3.9 kb 
BglII BglII NotI 
9.5 kb 
3.9 kb 
Igf2r P 
BglII BglII NotI 
9.5 kb 
Igf2r P 
EN4kb 
EN4kb 
Mat (wt) 
Pat (R2!) 
ND ND 
  36 
 
3.4 Chromatin immunoprecipitation shows active marks on a 
silenced promoter 
 
Chromatin Immunoprecipitation (ChIP) is a technique that is widely used to 
analyze DNA binding proteins and histone modifications. Here I used it to 
investigate the chromatin state of the Igf2r promoter in differentiating 
AirnPmove ES cells. It has been reported that methylation of the Igf2r 
promoter correlates with the presence the repressive H3K9me3 mark (Regha, 
Sloane et al. 2007). This mark in turn recruits the heterochromatin protein 
HP1, which leads to chromatin condension and transcriptional repression. I 
showed in section 3.1 that the paternal Igf2r promoter lacks secondary DNA-
methylation in differentiated AirnPmove ES cells. Therefore, I was interested 
to assay chromatin marks in the Igf2r promoter region in these cells to test if 
repressive chromatin marks occur in the absence of DNA methylation. Here I 
used an antibody against the tri-methylated lysine4 on histone 3 (H3K4me3) 
which is a mark associated with open chromatin and transcriptional activity 
and was shown to anti-correlate with the repressive H3K9me3 mark (Cheng 
and Blumenthal 2010).  
 
For these experiments I used the commercially available EZ-ChIP™ 
chromatin immunoprecipitation kit (Millipore). First, the cells were grown to a 
density of approx. 107 cells per 15 cm dish. An additional 10 cm dish was 
used for counting the cells and to isolate DNA for southern blotting.  
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3.4.1 Optimization of chromatin fragmentation  
For all ChIP techniques, the chromatin needs to be fragmented. The EZ-
ChIP™ protocol recommends to use sonication of the whole cell lysate. 
Depending on the cell type and the number of cells used for each assay, the 
sonication conditions need to be optimized to obtain the required fragment 
size of 200-1.000bp. Thus I had to optimize the experimental approach to use 
differentiated ES cells with the EZ-ChIP™ kit. According to the protocol I 
started with 1ml cell lysate from 107 cells and performed four sonication cycles 
(details see materials and methods) and took 20µl aliquots before and after 
the sonication. The same cell lysate was used for four additional sonication 
cycles and after each cycle a 20µl aliquot was taken. All aliquots were kept on 
ice until further processing. The aliquots were treated with RNaseA and 
Proteinase K according to the EZ- ChIP™ protocol, loaded onto a 1.5% 
agarose gel for electrophoresis and the DNA stained with ethidium bromide. I 
found that after 4 sonication cycles, the fragments were smaller than the 
desired size (Fig.6A). Therefore I tried three sonication cycles, which gave 
fragments of the expected size (Fig. 6B). Thus I used these conditions for the 
biological replicates dif9 and dif10. However, to increase the ChIP signals, for 
biological replicate dif11, I used 3x107 cells. I repeated the sonication 
optimization with an additional aliquot of 2.6x 107 R2∆/+ cells (Fig. 6C) and 
decided to use two sonication cycles, to obtain larger fragments. I used these 
conditions for sonication of chromatin from 3x107 differntiated +/FAP, +/RAP 
and R2∆/+ ES cells in the biological replicate dif11 (Fig 6D).  
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Figure 6: Optimization of chromatin fragmentation. 
Aliquots of unprocessed and sonicated chromatin were analyzed by gel electrophoresis on 
1,5% agarose gels. (A) sonication of chromatin obtained from 107 differentiated +/FAP cells. 
The majority of fragments were below 500bp after four sonication cycles and fragment size 
decreased with additional rounds of sonication. M: 100bp+ ladder. Note that no band for 
intact DNA is seen. (B) sonication of chromatin from 107 differentiated +/FAP cells, BRdif9 
(C) sonication optimization for approx. 3x107 cells, using 2.6x107 R2∆/+ cells. (D) sonication 
of chromatin from 3x107 cells from the +/FAP, +/RAP and R2∆/+ cell lines, BR dif11.  
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3.4.2 ChIP reveals active chromatin over the Igf2r promoter region in 
differentiated +/FAP ES cells 
 
I performed the first ChIP assays with crosslinked chromatin from 107 
differentiated +/FAP cells (biological replicate dif9), which was sonicated for 3 
cycles (see Fig. 6B). For each ChIP reaction, I used a 100µl aliquot of 
sheared chromatin, representing 106 cell equivalents. 1% of chromatin was 
taken after the pre-clearing step and set aside at 4ºC as the input. As a 
negative control I used an anti IgG antibody provided with the kit to control for 
unspecific binding of this antibody sub-class to chromatin. Following the 
immunoprecipitation and crosslink reversal, I purified the DNA using spin 
columns provided with the kit. For analysis of the ChIPed material, I used a 
standard PCR approach with 2µl of each ChIP-DNA sample.  
 
In a first attempt, I performed a scanning PCR over a 12kb region including 
the Igf2r promoter. The regions amplified by PCR are depicted in Fig. 7A for 
the maternal and paternal allele in +/FAP cells. Figures 7B+C show the 
results of the scanning PCR for two technical ChIP replicates. The input 
samples, which act as positive controls for the PCR gave signals with all used 
primers except the ones for region 23. However, I found that in both technical 
replicates, the input signals differed strongly in intensity between the different 
regions tested. The IgG negative control showed no signals, except for 
regions 14 and 22, where I observed specific bands of low to moderate 
intensity. H3K4me3 was enriched over regions 17, 18 and 19 which surround 
the Igf2r transcription start site. A weak band was also seen for regions 14, 20 
and 22. However, regions 14 and 22 were also seen in the IgG control and 
might be artefacts of an unspecific binding of DNA to the Protein G Agarose 
beads used for immunoprecipitation. For the second technical replicate, I 
additionally used two primer pairs that cover the AirnPmove region (primer 
pairs 6 and 7, see Fig.7A). Both primers gave no PCR product in the IgG 
negative control. In the input, both primers gave signals of the expected size.  
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However, the signal for region 6, which covers the transcriptional start site of 
Airn, was weaker. I found that both primer pairs gave signals in the H3K4me3-
ChIP (Fig. 7C), although the signal for region 6 is hardly detectable in the 
printout but was seen as a weak band in the original image.  
 
 
 
Figure 7: ChIP PCR over the Igf2r promoter region in differentiated +/FAP cells 
(A) Schematic representation of the maternal and paternal allele. Regions amplified with 
primer pairs 13-24 are displayed as light bars, regions 6 and 7 as dark blue bars. ex1: exon1 
of Igf2r. AirnPmove: moved Airn promoter region on the paternal FAP allele. T: transcription 
start site of Igf2r.T1: transcription start site of Airn. Scale bar: 500bp. (B)+(C) scanning PCR 
of ChIP-DNA for two technical replicates. Numbers indicate the regions shown in (A). TR2 
additionally shows PCR products over regions 6 and 7, marked by blue dotted frame. M: 
100bp+ ladder. 
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To obtain allele specific information for the Igf2r promoter, I designed primers 
that cover exon 1 of Igf2r, which includes the MluI SNP. In three biological 
replicates, the PCR showed specific bands for the Input and H3K4me3 ChIP 
(see Fig. 8A). I cut these bands from the gel and purified DNA using the 
Promega Wizard SV kit. The purified DNA was sequenced and sequencing 
results are shown in Fig. 8B. For the Input, which reflects the genomic DNA, I 
found that both alleles were equally present, seen by overlapping peaks for 
the paternal ‘T’ and the maternal ‘C’ nucleotides at the SNP position. For all 
three biological replicates the sequencing tracks for the ChIP-PCR products 
revealed that H3K4me3 is present on both alleles in differentiated +/FAP ES 
cells. In biological replicate dif11, I additionally investigated the presence of 
this chromatin modification in +/RAP cells. Here, the ChIP-PCR gave an 
intense band for H3K4me3 (see Fig.8A, bottom). I also used an antibody 
against RNAPII provided with the EZ-ChIP™ kit as a positive control. 
However, on the agarose gel I did not observe any signal enrichment for 
RNAPII (Pol2) over the IgG negative control (see Fig. 8A, bottom). The 
sequencing tracks show that both alleles are equally present in the input, and 
H3K4me3 is present at the maternal and the paternal allele in differentiated 
+/RAP cells. Taken together, these findings demonstrate that both, the active 
and the repressed Igf2r promoter carry an active chromatin mark. 
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Figure 8: ChIP PCR over exon1 of Igf2r and SNP sequencing. 
Three biological replicates are shown for +/FAP cells. The third replicate also contained the 
+/RAP cell line as a control. (A) ChIP-PCR products analyzed by agarose gel electrophoresis. 
Input and genomic DNA served as positive PCR controls, IgG and H2O as negative controls. 
Pol2: antibody against RNAPII provided with the EZ-ChIP™ kit to serve as a positive ChIP 
control. M: 100bp+ ladder. (B) quantitative sequencing of Input and H3K4me3 ChIP-PCR 
products. The ACGCG(T/C) sequence was correctly identified. The SNP position is 
highlighted in light blue. The paternal allele carries the ‘T’-SNP, the maternal allele the ‘C’-
SNP.  
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Part II: Investigation of non-coding RNA stability 
 
In this part of my Diploma thesis, I wanted to test the hypothesis that macro 
lncRNAs have a shorter half-life in comparison to the protein coding genes in 
the corresponding imprinted cluster. Here I used the NIH3T3 embryonic 
fibroblast cell line as a model. I blocked transcription with Actinomycin D 
(ActD) and isolated RNA from treated and control cells. To test for adverse 
effects of ActD or the solvent on cell viability, I monitored the cells by light 
microscopy. The isolated RNA was converted into cDNA, which was then 
used for quantitative real-time PCR (qPCR) assays. Thereby I monitored RNA 
decay at given time points after ActD treatment, compared to solvent and 
untreated controls. 
 
 
3.5 Optimization of ActD treatment and RNA quantitation 
 
In this section I tested different concentrations of Actinomycin D and its effect 
on NIH3T3 cells. Although mostly concentrations from 5 to 10µg/ml are used 
(Seidl, Stricker et al. 2006) (Chen, Ezzeddine et al. 2008) (Clark, Johnston et 
al. 2012), I performed the optimization to test for putative batch effects, as 
ActD is purified from a biological source rather than being synthesized under 
standardized conditions and thus might have variable efficacy. In a first 
screening, I tested three concentrations (1µg/ml, 5µg/ml and 10µg/ml) of ActD 
dissolved in 96% EtOH (RNA grade) for two time points (4h and 6h of ActD) 
and compared to an untreated control and a mock control that was treated 
with EtOH alone without addition of ActD. I used a highly concentrated stock 
solution of ActD (4000µg/ml) and made serial dilutions with medium to treat 
the cultured cells. The same dilution series was made with ethanol for the 
mock treatment. For optimizing the ActD concentration, I cultured NIH3T3 
cells in three 6well dishes and allowed them to grow to sub-confluency. Each 
6well dish was used for a given concentration of ActD or the corresponding 
amount of solvent. For the six hour treatment, I took off media from two wells 
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and added fresh medium, supplemented with either ActD or EtOH. After 2 
hours I treated the next two wells in the same manner for the 4h assay. The 
two remaining wells were left untreated. After a total of 6 hours, medium was 
carefully removed from all wells and cells were harvested using 1 ml of Trizol 
per well. This cell lysate was stored at -20ºC and processed within the next 
days. 
 
3.5.1 ActD does not affect cell viability  
To test if ActD or the solvent negatively affect cell viability, I monitored the 
cells under a light microscope with 5x magnification. Images were taken 
immediately before ActD treatment and at the end of the treatment, just before 
harvesting the cells. In this visual screening I found no changes in cell 
morphology during both, 4h and 6h treatment with ActD and EtOH compared 
to an untreated control (see Fig. 9). Thus, I conclude that ActD did not affect 
cell viability during the time course of the experiment at all concentrations 
tested.  
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Figure 9: Bright field light microscopy of cells before and after ActD or mock treatment. 
(A) NIH3T3 cells grown on a 6well dish treated with 1µg/ml Actinomycin D (ActD) or the 
corresponding volume of 96% Ethanol (EtOH). 4h before: image taken before addition of 
medium containing ActD or EtOH to the cells. 4h after: image of cells from the same well 4h after 
addition of ActD or EtOH. 6h before: image of cells from a different well taken before addition of 
ActD or EtOH to the cells. 6h after: image of cells from the same well 6h after addition of ActD or 
EtOH. Untreated: image of cells from a different well on the same 6well dish which was left with 
the same medium throughout the experiment. Image was taken at the same time as the 4h after 
and 6h after images. (B) same as (A) but cells treated with 5µg/ml ActD or the corresponding 
amount of EtOH (C) same as (A) but cells treated with 10µg/ml ActD or the corresponding 
amount of EtOH.  
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The RNA was isolated according to the protocol given in the materials and 
methods section, with the only change that the RNA pellet was dissolved in 35 
µl of RSS (RNA storage solution). 2µl of RNA in RSS were used for 
measuring the RNA concentration with a NanoDrop device, using RSS as a 
blank for the measurements (see Table 1).  
 
 
Table 1: RNA yield from NIH3T3 cells grown on 6well dishes 
RSS: RNA concentration of samples dissolved in 35µl RNA storage solution. Precipitated: 
value from RSS divided by 3.6 because samples were diluted with 2.5 volumes EtOH and 0.1 
volumes 3M NaAc. 6µg, 4µg: numbers give the volume of precipitated RNA that contains the 
indicated amount of RNA. Grey font: this sample was not used for further analysis. 
 
Because RNA concentrations in the RSS preparation were too low to start 
directly with cDNA preparation, I precipitated the RNA with EtOH and 3M 
NaAc (see materials and methods) over night at -20ºC.  
I used 4 µg of RNA for cDNA preparation, which was sufficient to make one 
reverse transcription reaction (+RT) and a negative control without reverse 
transcriptase (-RT). I controlled the quality of my cDNA preparation by a non-
quantitative PCR assay for the ubiquitously expressed housekeeping gene 
Gapdh (glyceraldehyde-3-phosphate dehydrogenase). As the PCR primers for 
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this assay lie within an intron of Gapdh, the presence of a PCR product in the 
–RT control would indicate a contamination with cDNA and/or genomic DNA. 
Figure 10 shows that the cDNA preparation was successful, seen by specific 
bands of the expected size on the agarose gel. The –RT controls showed no 
product, except for one sample, which showed a weak band in the –RT 
control (-RT of the 6h solvent control in the 1µg/ml series, marked by an 
asterisk in Fig. 10) 
 
 
 
Figure 10: Control gel for cDNA preparation 
cDNA was tested with primers for Gapdh which give a 469bp product. U1, U2 : untreated 
controls. A: ActD treated. E: EtOH mock treatment. M: 100bp+ ladder. ‘+’: +RT samples.  
‘-‘: –RT controls. Asterisk: this –RT sample shows a weak positive signal. 
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3.5.2 Comparison of three normalizing genes 
 
I proceeded with a quantitative real-time PCR (qPCR) assay, where I tested 3 
commonly used housekeeping genes (18S rRNA, Gapdh and Cyclophilin A) 
for their suitability to act as a normalizer in my experiments. To obtain a 
comparable set of data, I additionally performed assays for two RNAs with a 
known half-life, which were the macro lncRNA Airn (t1/2= 1.6-2.1h, (Seidl, 
Stricker et al. 2006)) and the mRNA of the transcription factor Myc (t1/2= 33 
min in N2a cells  (Clark, Johnston et al. 2012)). Figure 11 shows the 
unnormalized qPCR data for the three housekeeping genes. With all three 
housekeeping genes I observed that one sample (EtOH 4h of the 5µg/ml 
series, see * in Fig.11) was devoid of RNA. Although I used the same amount 
of RNA for each cDNA preparation, I observed strong differences in RNA 
abundance. In general, samples that showed enrichment for one normalizing 
gene also showed enrichment with the other normalizing genes. However, for 
some samples I observed a difference in RNA abundance when comparing 
the samples to one another (Fig. 11). This was a first indication that careful 
selection of the normalizing gene is required.  
 
Next, I used these data to normalize the qPCR data for Airn and myc. Results 
are shown in Figure 12. 18S rRNA normalization showed over 10-fold 
difference between some solvent control samples, whereas Cyclophilin A 
(CypA) and Gapdh showed less distinct differences in relative RNA levels 
between untreated and solvent control samples. Data normalized to CypA 
showed similar RNA levels for the solvent and untreated controls in the Airn 
qPCR assay(Fig. 12B, left), except the untreated 10µg/ml control, which also 
showed a high technical variation (Fig.12 B+C). In contrast, myc normalized 
to CypA showed higher variation between solvent and untreated controls (Fig. 
12B, right). When I used Gapdh to normalize the myc qPCR data, I found only 
minor differences between the solvent and the untreated controls. 
Additionally, RNA levels in the ActD treated samples showed a stronger 
reduction with increasing ActD concentrations (Fig. 12C, right). However, 
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results for Airn normalized to Gapdh showed that solvent controls were 
strongly reduced compared to untreated control samples. (Fig. 12C, left).  
 
 
Figure 11: Comparison of housekeeping gene RNA levels. 
Unnormalized qPCR data of +RT samples are shown. Error bars represent the technical 
variation of qPCR assays. The value for the untreated control in the 1µg/ml series was set to 
100%, the other values are shown relative to this. Asterisk: data indicates that RNA from this 
sample was lost.  
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Figure 12: qPCR results for the optimization test 
Relative levels of Airn and Myc RNA assayed with qPCR are shown. Error bars represent the 
technical variation of the qPCR assays. (A) data normalized to 18S rRNA. (B) data 
normalized to Cyclophilin A (CypA). (C) data normalized to Gapdh. Asterisk: this sample was 
devoid of RNA, thus the data is not reliable.  
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These data indicate that both, the solvent as well as the treatment of the cells 
might have an effect on the outcome of the experiment. Therefore, based on 
the results of this optimization, I made the following decisions for the following 
experiments: 
 
o Use the highest ActD concentration tested (10 µg/ml), which efficiently 
blocked RNA synthesis and did not affect cell survival during six hours 
of treatment. 
o Use Gapdh as normalizing gene for quantitative PCR.  
o Use 4 hours ActD treatment in following experiments. 
o Try another solvent (DMSO), to test for putative solvent effects. 
o Treat all dishes technically the same way to obtain comparable results: 
remove media from all dishes, add solvent or ActD, transfer media 
back to the same dish. Minimize the time cells are outside the 
incubator. 
o Perform the experiment in duplicates, one for qPCR analysis, the other 
one to be stored for future experiments. 
 
3.6 Effect of solvents and media change 
 
Based on the results of the optimization, I designed another experiment with 
the following settings: 
I plated a defined number (3x106 cells) of NIH3T3 cells on 10cm dishes and 
allowed them to settle for 24h. Then I took off the medium and transferred it 
into either an empty tube, a tube containing the solvent alone or 
ActD+solvent. Next, I mixed the media briefly by pipetting up and down and 
immediately transferred it back to the dishes in the same order as I took the 
medium off. Thereby I aimed to treat all dishes technically in the same way, 
and minimize variation between ActD treated and control dishes, which may 
arise from different time points of being without medium. Additionally, the cells 
were treated with the same medium in which they had been cultured before, 
instead of applying fresh medium.  
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This experiment was done in duplicates, thus I had four series, two with EtOH 
(series “A” and “B”) as the solvent, and two with DMSO (series ”C” and “D”) as 
the solvent. Images taken before and after the treatment show no difference 
in the appearance of the cells, thus indicating that neither Actinomycin D nor 
the solvents EtOH and DMSO negatively affected cell viability during the 
timeframe of the experiment (see Fig. 13). After 4 hours of treatment the cells 
were harvested in 2ml Trizol and the lysate stored at -20ºC. Lysate from 
series “B” and “D” were used for further experiments.  
 
Figure 13: bright field light microscopy images of NIH3T3 cells before and after 
treatment.  
Images of the same region of each dish were taken immediately before and after 4h 
treatment. No changes in cell morphology are visible. (A) EtOH series “B”. (B) DMSO series 
“D”. 
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3.7. Unspliced macro lncRNAs are unstable transcripts  
I used one ml of cell lysate in Trizol from one EtOH series (series”B”) and one 
DMSO series (series”D”) for RNA isolation and cDNA preparation according 
to the protocols given in the materials and methods section. The cDNA was 
made from 6µg RNA, giving two +RT reactions and one –RT reaction. Again, 
as in the optimization experiment I controlled cDNA quality by non-quantitative 
PCR to test for contaminations. As shown in Fig. 14, the negative controls did 
not give a product, and a specific product was seen for all +RT reactions.  
 
 
 
Figure 14: non quantitative PCR for Gapdh 
Agarose gel electrophoresis of cDNA tested with primers for Gapdh which give a 469bp 
product. “+”: +RT samples. “-“: –RT samples.  
 
 
I proceeded with qPCR assays to test for the relative abundance of the 
following RNAs: Myc and Airn, which were already used in the optimization 
experiment, the two long non-coding RNAs H19 and Kcnq1ot1 (both 
described in section 2.4) and a splice variant of Airn (SV1). Results of the 
qPCRs are shown in Fig. 15A. 
 
 
EtOH DMSO 
+   -    +   -   +   -   +   -   +   -   +   - 
496bp 
B1: untreated 
B2: EtOH 
B3: EtOH+ActD 
D1: untreated 
D2: DMSO 
D3: DMSO+ActD 
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The values were set relative to the value of sample B2, which was set to 
100%. I found that Myc, Airn and Kcnq1ot1 showed a considerable reduction 
upon ActD treatment. Myc was reduced to less than 5% of the EtOH control, 
Airn was approx. 20% and Kcnq1ot1 approx. 25% of the EtOH control (Fig. 
15A). Surprisingly, levels of H19 were not reduced upon ActD treatment, but 
instead H19 was 160% of the EtOH control. The Airn splice variant 1 (SV1) 
showed a minor reduction to approximately 70 % of the solvent control.  
 
The samples with DMSO as the solvent showed similar trends, although the 
values differed (see Fig. 15A). Notably, Airn and Airn-SV1 levels were less 
reduced in the DMSO series compared to the ETOH series. Additionally, I 
found that in all qPCR assays the untreated samples (B1, D1, shown as blue 
bars in Fig. 15A) showed high variation between one another for each gene 
tested. Because of these alterations between the untreated samples, I 
decided to make a technical replicate of the cDNA preparation and then 
perform the same qPCR assays as before. For some RNA samples I had less 
than 6µg left, thus for the second technical replicate I could only carry out one 
+RT reaction and one –RT reaction instead of two +RT and one –RT reaction 
as in the first technical replicate. I used the cDNA for a qPCR analysis in the 
same manner as for the 1st technical replicate. Data are shown in Fig. 15 B.  
 
Although the values varied between the two replicates, I observed similar 
trends. Myc showed a significant reduction and was reduced to less than 5% 
of the solvent control after 4 hours and Airn was 20% of the EtOH solvent 
control, which corresponds to its published half-life. (Seidl et al, 2006). Also, 
Kcnq1ot1, H19 and Airn-SV1 showed similar relative abundances in the two 
replicates when compared to the corresponding solvent controls. However, I 
observed a high variation between the untreated samples in both replicates 
(light blue bars in Fig. 15A+B). 
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Figure 15: qPCR data from two independent cDNA preparations  
Relative levels of RNA are shown on the vertical axis. Horizontal axis shows the different 
samples. Error bars represent technical variation of the qPCR assays. The value for the EtOH 
solvent control (sampleB2) was set to 100% in all graphs. The other RNA levels are shown 
relative to this value. All data were normalized to Gapdh. (A) Technical replicate 1. (B) Technical 
replicate 2.  
s
h
o
r
t
 
h
a
lf
-
li
f
e
lo
n
g
 
h
a
lf
-
li
f
e
 EtOH DMSO  EtOH DMSO
(A) TR1 (B) TR2
!"
#!"
$!"
%!"
&!"
'!!"
'#!"
'$!"
'%!"
'&!"
('" (#" ()" *'" *#" *)"
!"
#$
%
&
"
'(
)
*
'#
"
&
"
#+
',
-
.'
*/!01234''
!"
#!"
$!"
%!"
&!"
'!!"
'#!"
'$!"
('" (#" ()" *'" *#" *)"
!"
#$
%
&
"
'(
)
*
'#
"
&
"
#+
',
-
.'
*/!0'
!"
#!"
$!"
%!"
&!"
'!!"
'#!"
'$!"
'%!"
'&!"
('" (#" ()" *'" *#" *)"
!"
#$
%
&
"
'(
)
*
'#
"
&
"
#+
',
-
.'
/01'
!"
#!"
$!"
%!"
&!"
'!!"
'#!"
'$!"
'%!"
('" (#" ()" *'" *#" *)"
!"
#$
%
&
"
'(
)
*
'#
"
&
"
#+
',
-
.'
/01'
!"
#!"
$!"
%!"
&!"
'!!"
'#!"
('" (#" ()" *'" *#" *)"
!"
#$
%
&
"
'(
)
*
'#
"
&
"
#+
',
-
.'
/0123453'
!"
#!"
$!"
%!"
&!"
'!!"
'#!"
'$!"
'%!"
'&!"
#!!"
##!"
#$!"
('" (#" ()" *'" *#" *)"
!"
#$
%
&
"
'(
)
*
'#
"
&
"
#+
',
-
.'
*/!01234'
!"
#!"
$!"
%!"
&!"
'!!"
'#!"
'$!"
'%!"
('" (#" ()" *'" *#" *)"
!"
#$
%
&
"
'(
)
*
'#
"
&
"
#+
',
-
.'
*/!0'
!"
#!"
$!"
%!"
&!"
'!!"
'#!"
'$!"
('" (#" ()" *'" *#" *)"
!"
#$
%
&
"
'(
)
*
'#
"
&
"
#+
',
-
.'
/01'
!"
#!"
$!"
%!"
&!"
'!!"
'#!"
'$!"
'%!"
'&!"
#!!"
('" (#" ()" *'" *#" *)"
!"
#$
%
&
"
'(
)
*
'#
"
&
"
#+
',
-
.'
/0123453'
!"
#!"
$!"
%!"
&!"
'!!"
'#!"
'$!"
'%!"
'&!"
#!!"
('" (#" ()" *'" *#" *)"
!"
#$
%
&
"
'(
)
*
'#
"
&
"
#+
',
-
.'
/01'
  56 
 
 
To flatten the variations between the replicates, I pooled the data and again 
plotted the RNA abundance relative to sample B2 (see Fig. 16A) From this 
pooled data, I calculated ratios to show RNA abundance in ActD treated 
samples as percentage of the corresponding solvent control, which was set to 
100% (see Fig. 16B). In general, in the samples where I used EtOH as the 
solvent, I observed a stronger reduction of unstable RNAs and a higher 
increase of the stable H19 ncRNA. For example, Myc was reduced to 1,9% 
when EtOH was the solvent and to 2.6% when DMSO was used However, the 
two different solvents had a minor influence on the levels of Kcnq1ot1 and 
H19 after ActD treatment, as these RNAs showed little variation between the 
two solvents. In contrast, Airn was reduced to 16% when EtOH was used as 
the solvent, whereas it was only reduced to 40% of the DMSO solvent control. 
Also, the Airn splice variant SV1 was reduced less in the DMSO series (94%) 
compared to the EtOH (72%) series. Thus, DMSO appears to have a 
stabilizing effect on Airn but not on the other RNAs tested. 
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Figure 16: Pooled data from technical replicates TR1 and TR2 
(A) pooled data from TR1 and TR2 (shown in Fig. 15) Error bars give the variation of the 
mean values from these replicates. (B) RNA levels after 4h ActD treatment shown as 
percentage of the corresponding solvent controls (solvent value set to 100%). The values for 
EtOH and DMSO were compared using a paired t-test (* P=0.01-0.05). 
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4. Discussion 
 
Part I: Features of a promoter silenced by a macro 
lncRNA  
 
4.1. Summary of results: 
 
In the first part of my Diploma thesis, I used an in vitro ES cell differentiation 
system to investigate the Igf2r promoter chromatin state in AirnPmove 
(+/FAP, +/RAP) ES cells. I showed that in differentiated +/FAP and +/RAP ES 
cells the Igf2r promoter lacks a secondary DNA methylation that is usually 
observed in wildtype cells. Igf2r was expressed biallelically in +/RAP cells, but 
despite the lack of secondary methylation showed imprinted expression in 
+/FAP cells. Chromatin immunoprecipitation showed that the Igf2r promoter 
region displays active chromatin. Quantitative SNP sequencing revealed that 
both, the maternal and the paternal allele carry the active H3K4me3 
chromatin mark over the Igf2r promoter in differentiated +/FAP and +/RAP ES 
cells. These findings indicate that imprinted expression of Igf2r is independent 
of repressive epigenetic modifications and opens the possibility that Airn 
transcription is sufficient to silence Igf2r on the paternal allele. 
 
4.2. Role of DNA methylation and histone modifications in 
Igf2r silencing  
 
4.2.1 Paternal repression of Igf2r is correlated with repressive histone 
modifications  
 
In the wild type situation, DNA methylation and heterochromatinization occur 
at the silenced paternal Igf2r promoter. Here, DNA methylation correlates with 
the presence of the repressive H3K9me3 chromatin mark, which is associated 
with transcriptional repression and is most likely mediated by the histone 
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methyltransferase ESET (Regha, Sloane et al. 2007). Latos et al. showed that 
in undifferentiated ES cells the Igf2r promoter is unmethylated and devoid of 
H3K9me3. However, upon in vitro differentiation, the Igf2r promoter gained de 
novo methylation and acquired the repressive H3K9me3 mark (Latos, Stricker 
et al. 2009).  The finding that the H3K9me3 mark is lost when Airn is 
truncated to 3kb, and Igf2r is not silenced was an indication that full length 
Airn could be required for acquisition of this repressive chromatin mark 
(Regha, Sloane et al. 2007; Latos, Stricker et al. 2009). Consistent with this 
hypothesis, it was demonstrated that in placenta Airn interacts with the 
histone methyltransferase G9a, which is capable of generating the repressive 
H3K9me3 mark. However, G9a was enriched over the Slc22a3 promoter but 
not over the Igf2r promoter (Nagano, Mitchell et al. 2008). Thus, silencing of 
EXEL (extra embryonic lineage) imprinted genes might depend on different 
mechanisms than silencing of ML (multi lineage) imprinted genes. 
 
4.2.2 Igf2r silencing does not depend on repressive histone 
modifications  
 
Differentiated AirnPmove ES cells show a different methylation pattern and 
histone modifications compared to wild type ES cells. In section 3.3 I showed 
that the Igf2r promoter (DMR1) lacks DNA methylation in +/FAP and +/RAP 
ES cells which were differentiated for 5 days with retinoic acid. This result is in 
accordance with the previous finding that AirnPmove cells lack secondary 
methylation on the Igf2r promoter (Latos, Pauler et al. manuscript in 
progress). This result was expected for +/RAP cells, where the paternal Igf2r 
promoter is not silenced and Igf2r is expressed biallelically. However, in 
+/FAP cells Igf2r shows imprinted expression despite the lack of this 
secondary methylation. I showed that imprinted Igf2r expression does not 
depend on the gain of DNA methylation on its promoter in +/FAP cells. This is 
consistent with the previous finding that DNA methylation has no direct role in 
repression of Igf2r, as mouse embryos deficient of DNA methylation also 
showed silencing of Igf2r (Li, Beard et al. 1993; Seidl, Stricker et al. 2006). As 
DNA methylation correlates with the gain of repressive histone marks, the 
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unmethylated Igf2r promoter on the FAP allele allows to dissect the gain of 
repressive histone modifications and Igf2r silencing. 
 
ChIP-PCR and quantitative sequencing revealed that both alleles carry the 
active H3K4me3 chromatin mark over exon1 of Igf2r in differentiated +/FAP 
and +/RAP cells. In the scanning PCRs I found that the H3K4me3 extends 
over the regions 17, 18 and 19, which include approx. 3kb of the Igf2r 
promoter on the wt allele (see Fig.7). Additionally, I found H3K4me3 over 
regions 6 and 7 which lie within the Airn promoter region. The scanning PCR 
assay, however, was not able to distinguish between the maternal and 
paternal allele. Nevertheless, as the maternal Airn promoter is silenced by a 
methylation imprint in +/FAP ES cells, I hypothesize that the signals found 
with these primers correspond to the paternal Airn promoter. Thus, the FAP 
allele carries a 5.5kb long region of open chromatin, which includes both, the 
Airn and the Igf2r promoter. As H3K4me3 anti-correlates with the repressive 
H3K9me3 mark (Cheng and Blumenthal 2010), I hypothesize that repression 
of paternal Igf2r expression is independent of the presence of repressive 
chromatin marks. Consistent with this hypothesis, H3K9me3 enrichment over 
the Igf2r promoter was found to be 10 times lower than on the repressed Airn 
promoter in +/FAP cells (Latos, Pauler et al. manuscript in progress).  
 
4.3 Proximity of the active Airn CGI might cause the lack of 
repressive histone modifications over the Igf2r promoter   
In section 3.3 I showed that in contrast to the control cell line R2∆/+, +/FAP 
and +/RAP cells lack somatic DNA methylation over the paternal Igf2r 
promoter after 5 days of differentiation. Thus, although the insertion of the 
Airn promoter had no negative positional effect on Igf2r promoter integrity 
(Latos, Pauler et al. manuscript in progress), the epigenetic state of the Igf2r 
promoter chromatin was altered. As both, the Airn and the Igf2r promoters are 
GpG island (CGI) promoters, it is possible that the generation of the 
AirnPmove alleles had a direct influence on the methylation state of the Igf2r 
promoter DMR. I hypothesize that the insertion of the Airn promoter 
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immediately downstream of the Igf2r promoter lead to the generation of a 
novel, extended CpG rich region. I tested this hypothesis in silico by plotting 
the abundance of C and G nucleotides over the in the FAP allele using the 
web-based application EMBOSS explorer (http://emboss.bioinformatics.nl/). 
Thereby, I found that the FAP allele displays a novel 3kb GC rich region over 
the Airn and Igf2r promoters (Fig. 17). I hypothesize that this new CpG rich 
region is resistant to de novo DNA methylation.  
 
In general, promoter associated CGIs display an open chromatin structure 
and histone modifications associated with transcriptional activity, like 
H3K4me3. The CGI promoter chromatin shows reduced levels of histone H1 
and is sensitive to endonuclease restriction. The histones H3 and H4 are 
hyper-acetylated at CGIs which is characteristic for transcriptional activity. 
Often, the chromatin is even nucleosome-free (Kundu and Rao 1999). In 
contrast, DNA methylation at CGIs is rare and correlates with the presence of 
H3K9me3 and absence of H3K4me3 (Cheng and Blumenthal 2010). DNA 
methylation is mediated by DNA methyl transferases (DNMTs, see section 
2.1.2). It was demonstrated that the presence of the H3K4me3 chromatin 
mark blocks the activity of DNMT3L which is an essential co-factor for 
DNMT3A2 (Ooi, O'Donnell et al. 2009). Thus H3K4me3 inhibits de novo DNA 
methylation. This is supported by recent findings in the Gnas cluster, which 
indicate that H3K4me3 is required for maintaining a methylation free state 
over somatic DMRs. However, the presence of a non-coding RNA or its 
transcription could lower H3K4me3 levels and thus allow DNA methylation 
(Williamson, Ball et al. 2011).  
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Figure 17: CG richness over the Igf2r and Airn promoter regions in the FAP allele 
(A) Graphic representation of the Igf2r and Airn promoter region on the FAP allele. Blue 
region: moved Airn promoter; grey region: exon1 of Igf2r; T1: Airn TSS; T: Igf2r TSS; MluI: 
restriction site for MluI. (B) CpG plot of the region showed in A, using EMBOSS explorer. 
Upper panel: ratio of observed GpG dinucleotides over expected. Middle panel: percentage of 
C + G nucleotides. Lower panel: CpG islands calculated with following thresholds: 
observed/expected ratio > 0.60; percent C + percent G > 50.00; Length > 200nt  
 
 
(A) FAP allele
(B) CpG plot
T1
T
MluI MluI
500bp
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As the active Airn promoter also carries the H3K4me3 chromatin mark 
(Regha, Sloane et al. 2007), it is likely that the insertion of the Airn promoter 
immediately upstream the Igf2r promoter blocked de novo methylation of the 
Igf2r promoter CGI. Thus, the generation of the FAP allele potentially lead to 
spreading of active chromatin marks from the active Airn promoter to the Igf2r 
CGI, thereby inhibiting secondary methylation. 
 
Taken together, I conclude that the FAP allele displays a 5.5kb region of open 
chromatin, which includes a novel 3kb CpG rich region. Nevertheless Airn 
was able to silence Igf2r in +/FAP ES cells. Thus, I state that despite their 
coincidence in the wildtype, somatic DNA methylation and epigenetic gene 
silencing by macro lncRNAs are independent mechanisms. This is supported 
by observations in Dnmt1 null mice, where Igf2r is still silenced by Airn in the 
embryo and in visceral endoderm (Li, Beard et al. 1993; Hudson, Seidl et al. 
2011) 
 
 
4.4 How does Airn silence gene expression? 
 
Airn was demonstrated to be responsible for cis silencing of Igf2r in all 
embryonic tissues of the mouse and the Slc22a2 and Slc22a3 genes 
(Sleutels, Zwart et al. 2002), which show imprinted expression in extra-
embryonic lineages (EXEL). However, Airn overlaps with the Igf2r gene but 
not with the EXEL imprinted genes. Thus, Airn can act either as a short-range 
repressor, silencing overlapping genes or as a long-range repressor that 
silences non-overlapping genes on the same chromosome (Pauler, Hudson 
2012). Thus, gene silencing by Airn might function by different mechanisms in 
the embryo and in extra-embryonic tissues.  
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4.4.1 Which model do my results fit best? 
 
Airn expressed from the FAP allele lacks the first 27kb of the wt transcript. 
Nevertheless it was able to silence Igf2r in cis. Therefore, a functional role for 
these first 27kb at the 5’end of Airn can be ruled out. Thus, together with data 
from the 3’truncations, the functional length of Airn can be narrowed down to 
a stretch of 4kb including the Igf2r promoter (Latos, Pauler et al. manuscript in 
progress) (see also Fig.2). The RNA product from this 4kb region might either 
function on the level of RNA or transcription.  
 
4.4.2 Igf2r is most likely silenced by transcriptional interference (TI) 
 
I showed that in +/FAP cells, Airn silences paternal Igf2r in the absence of 
repressive epigenetic marks. The fact that the Airn truncations which do not 
overlap the Igf2r promoter failed to silence Igf2r was a first indication that 
transcriptional overlap is required. In an earlier study, replacement of the Igf2r 
promoter with a viral TKneo promoter did not affect imprinted expression of 
Airn, Slc22a2 and Slc22a3 (Sleutels, Tjon et al. 2003). The finding that Airn 
was able to silence the TKneo promoter driven transcript on the paternal allele 
indicated that gene silencing by Airn does not depend on the endogenous 
sequence. If silencing was dependent on the Airn transcript, a conserved 
structure between the Igf2r promoter and the TKneo promoter would be 
required. The finding that the Igf2r promoter and the TKneo cassette lack 
sequence conservation and their transcripts do not show structural similarity 
provides further evidence that Igf2r silencing is independent on the Airn RNA 
product (Latos, Pauler et al. manuscript in progress). The initial steps in TI are 
predicted to depend on two active promoters (Shearwin, Callen et al. 2005; 
Palmer, Egan et al. 2011). Thus, the finding that in +/FAP cells the paternal 
Igf2r promoter carries the H3K4me3 mark associated with transcriptional 
activity, was a direct hint that TI occurs. Taken together, my findings 
combined with the data found by Latos et al. strongly support the model that 
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transcription of Airn through the paternal Igf2r promoter is sufficient to silence 
paternal Igf2r expression.  
 
The TI model explains silencing of Igf2r by Airn, but fails to illustrate how non-
overlapping genes are silenced in an RNA independent mechanism. Pauler et 
al. proposed a model to explain how TI can repress non-overlapping genes. 
The model is based on the formation of a chromosomal loop, which brings the 
EXEL imprinted genes into close proximity to transcriptional activators, thus 
allowing the expression of these genes. On the paternal allele, Airn 
transcription over the activator binding sites interferes with the binding of 
transcriptional activators, which prevents the upregulation of EXEL imprinted 
genes. The repressed state is then stabilized by the recruitment of histone 
modifying enzymes, which lead to the generation of a repressive chromatin 
compartment (Pauler, Barlow et al. 2012).  
 
 
Part II: Investigation of ncRNA stability 
 
4.5 Summary of results: 
 
In the second part of my Diploma thesis, I set up a cell culture system to 
investigate the stability of lncRNAs, using the transcriptional repressor 
Actinomycin D (ActD). I controlled the reliability of this system by using two 
RNAs with a known half-life, the short-lived mRNA myc and the macro 
lncRNA Airn. Both showed reduction of RNA levels consistent with their 
published half-lives. The unspliced lncRNAs (Airn, Kcnq1ot1) showed a 
stronger reduction than the spliced RNAs (Airn-SV1 and H19), and H19 RNA 
even showed upregulation upon ActD treatment. ActD did not affect cell 
viability during the time frame of the experiments. However, I found that the 
solvent used for ActD can affect the outcome of the experiments. 
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4.6 Solvent effects 
 
In section 3.6. I showed images of NIH3T3 cells before and after treatment 
with ActD and the solvents ethanol (EtOH) and dimethyl sulfoxide (DMSO). 
From the visual inspection I did not observe any change in cell morphology 
(see Fig. 13). Thus I conclude that neither the solvents nor ActD have an 
immediately cytotoxic effect during the time course of the experiment. 
However, I cannot rule out that the solvents or ActD have effects on gene 
regulation or induce stress response pathways in the cells. In the pooled 
qPCR data (see Fig. 16), I found that EtOH had no major influence, as RNA 
levels in untreated and solvent controls were comparable. In the DMSO 
series, I observed a reduction of RNA levels in the solvent control for all RNAs 
tested (except Kcnq1ot1), compared to the untreated control. Additionally, 
RNA levels were generally reduced in the DMSO solvent control compared to 
the EtOH solvent control (Fig. 16A). When I directly compared RNA levels 
after ActD treatment to the corresponding solvent control (Fig. 16B), I found 
that ActD had a stronger effect in the EtOH series. The unstable RNAs Myc, 
Airn and Kcnq1ot1 showed a stronger reduction compared to the DMSO 
series. This trend was also seen for the Airn splice variant SV1. A paired t-test 
revealed that the difference between the EtOH and DMSO series was 
statistically significant only for Airn but not for the other genes tested; however 
I cannot rule out that DMSO has adverse effects on cultured NIH3T3 cells.  
 
Despite the frequent use of DMSO as an amphiphilic solvent for in vitro 
experiments, a multitude of side effects were reported (reviewed in (Santos, 
Figueira-Coelho et al. 2003). For example it was shown that DMSO negatively 
affects in vitro proliferation of bovine choriocapillary endothelial (CCE) cells 
(Eter and Spitznas 2002). In 1983, Edwards et al. demonstrated that DMSO 
induces differentiation of embryonic carcinoma (EC) cells into muscle cells 
(Edwards, Harris et al. 1983). This effect was already observed with low dose 
(0.25%) of DMSO and increased with higher concentrations. Notably, the 
authors found that DMSO is not required to be present during the whole time 
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of differentiation. Recently, it was demonstrated that DMSO negatively affects 
in vitro migration, proliferation and colony forming ability of the human CL1–5 
cancer cell line by upregulation of the tumor suppressor HLJ1 (Wang, Lin et 
al. 2012). The effect was concentration-dependent and specific for DMSO, as 
a control treatment with Ethanol (final concentrations ranging from 0-5%) had 
no effect on the HLJ1 levels. However, DMSO had no immediate cytotoxic 
effect with final concentrations up to 2% (v/v) during 48h incubation. 
 
The examples above illustrate the various effects DMSO can have on different 
cells lines. In my experiments, I used highly concentrated stock solutions of 
ActD to minimize the amount of solvent added to cell culture medium and the 
final solvent concentration was 0,25% (v/v). However, this concentration 
already had negative effects on EC cells (Edwards, Harris et al. 1983). Thus, 
based on my results and the published data I conclude that EtOH is a more 
suitable solvent than DMSO to be used in cell culture experiments. 
 
 
4.7 Choosing the normalizing gene for qPCR assays 
 
Quantification of RNA levels relies on normalization to a stable RNA, which is 
constitutively expressed and not affected by experimental conditions. For my 
qPCR assays, I tested three different RNAs for their suitability to acts as 
normalizing gene.  
 
18S rRNA is commonly used as a housekeeper because of its high stability 
and abundance. However, 18S rRNA is a RNAPI transcript and thus has 
different degradation characteristics compared to RNAPII transcripts. This 
might create a bias when normalizing RNAPII transcripts to 18S rRNA levels. 
Additionally, the high abundance of ribosomal RNA could be a problem in 
quantification (Bustin 2000), as minor differences in CT values already lead to 
high differences in the total RNA amount. For 18S rRNA, I observed 
saturation already before 10 qPCR cycles; thus the curves obtained in the 
qPCR might not be reliable. Also, for some samples which showed similar 
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abundance when normalizing to Gapdh or CypA, I observed a strong 
divergence when 18S rRNA was used for normalization. Another drawback for 
the use of ribosomal RNA could be the mode of action of ActD. Sobell et al. 
proposed a model in which ActD intercalates into a pre-melted form of DNA 
(beta DNA) found within the transcriptional complex. Thereby, progression of 
RNA polymerases is blocked, which inhibits elongation of nascent RNA 
chains, but does not interfere with initiation of transcription (Sobell 1985). 
Interestingly, it was reported that ribosomal RNA (rRNA) genes are especially 
sensitive to ActD. A possible explanation is that ActD enhances the covalent 
binding of topoisomeraseI to DNA. TopoisomeraseI is preferentially located in 
the nucleolus, where transcription of rRNA genes by RNA polymerase I 
(RNAPI) takes place. The formation of a covalent DNA-TopoisomeraseI 
intermediate is an ordinary process to relax supercoiled DNA which allows 
processing of the transcriptional complex. However, upon treatment with low 
levels of ActD (final concentration <1µg/ml) the covalent binding is enhanced 
which blocks progression of the transcriptional complex. This could explain 
why RNAPI transcripts are more sensitive to ActD than RNA polymerases II 
and III (Trask and Muller 1988). Taken together, I conclude that 18S rRNA is 
not suitable to be used for qPCR normalization in ActD experiments.   
In contrast to 18S rRNA, Gapdh and CypA are protein coding genes, thus 
being transcribed by RNAPII. Both act as housekeeping genes and are 
commonly used for qPCR normalization. In my qPCR assays I found that in 
contrast to 18S rRNA, both are suitable to act as normalizing genes:  the 
solvent control samples showed comparable values, and Airn and myc levels 
were reduced to levels consistent with their published half-lives (see Fig. 12). 
A previous study in NIH3T3 cells also showed that Gapdh mRNA levels did 
not change during 8h treatment with 10µg/ml ActD (Seidl, Stricker et al. 
2006). Therefore I decided to use Gapdh as the normalizing gene in my 
experiments, as both, my results and published data indicate that Gapdh is an 
appropriate reference gene.  
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4.8 H19 is an atypical transcript  
Based on the mode of Action for ActD, I expected all tested RNAs to be 
downregulated upon ActD treatment. Contrary to this, I found that H19 was 
upregulated approximately 1.5-fold upon treatment with ActD. I observed this 
phenomenon in both technical replicates, independent on the solvent used 
(Fig.15+16). To explain this peculiar behaviour of H19, I hypothesize that H19 
is regulated by transcriptional or posttranscriptional mechanisms which are 
affected upon ActD treatment. I first looked for obvious differences between 
H19 and the other genes tested. Using the UCSC genome browser 
(http://genome.ucsc.edu/) with the recent version of the mouse genome, I 
found that in contrast to the other tested RNAs (Airn, myc, Kcnq1ot1), the H19 
promoter region lacks a CpG island. As described in section 2.6, ActD 
preferentially intercalates into GC rich regions. The fact that H19 lacks GpG 
islands at its promoter and also within the gene body opens the possibility that 
H19 transcription might be less affect by ActD than transcription of RNAs that 
have a CpG island in their promoter. Thus, inefficient transcriptional blocking 
could explain why H19 is enriched in the ActD treated samples. Another 
explanation is that ActD enhances the binding of CTCF to the H19 DMD. 
Based on the boundary model introduced in section 2.4.3 this would result in 
elevated H19 levels and a reduction of Igf2 expression. It was demonstrated 
that ActD can enhance binding between DNA and protein, as it was shown for 
Topoisomerase I (see section 4.7). However, up to date it remains elusive, if 
ActD has a similar effect on the CTCF binding efficiency.   
 
Another possible explanation is that ActD interferes with post-transcriptional 
regulation mechanisms. I hypothesize that the steady state levels of the stable 
H19 transcript would depend on regulation by an unknown factor in untreated 
cells. This putative factor would be an unstable protein, whose mRNA has a 
short half-life. Thus, upon transcriptional block by Actinomycin D, the factor 
would decay rapidly, resulting in an increase of cellular H19 levels. A similar 
model for post-transcriptional regulation of H19 was introduced by Milligan et 
al., who proposed the existence of a short-lived trans-acting factor that 
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stabilizes H19 RNA levels (Milligan, Antoine et al. 2000). The authors used a 
mouse skeletal muscle cell line (C2C12) that highly expresses H19. 
Interestingly, inhibition of protein synthesis shortened the half-life of H19 to 
approx. 4h. However, transcriptional block with 5µg/ml ActD had no effect on 
overall H19 levels assayed by northern blotting. Thus the authors state that 
stabilization of the H19 RNA could be coupled to translation by a short-lived 
trans-acting factor. However, in contrast to my hypothesis, the factor 
introduced by Milligan et al. is proposed to stabilize H19 whereas in my 
hypothesis, the factor would be involved in H19 degradation. Nevertheless, 
both models are an indication that H19 is subject to posttranscriptional 
regulation.  
 
4.9 Alternative methods for half-life determination  
The unexpected behaviour of H19 illustrates than ActD in some cases 
interferes with half-life determination. Global block of transcription with ActD 
or other inhibitors is known to induce stress response mechanisms. Friedel et 
al. also demonstrated that half-lives determined by transcriptional blocking 
methods are imprecise for medium- and long-lived RNAs, and specific RNAs 
can be stabilized upon ActD treatment. (Friedel, Dolken et al. 2009). 
Additionally, it was reported that half-lives determined by ActD based methods 
can differ from data obtained by other methods, which do not block 
transcription (Ross 1995). Therefore I want to compare ActD treatment with 
two alternative methods.  
 
4.9.1 Pulse-chase methods using nucleotide analogs 
 
A recent publication (Tani, Mizutani et al. 2012) introduced a new method to 
assay RNA half-lives, the BRIC (5’-bromo-uridine immunoprecipitation chase) 
method. Here, the non-toxic nucleotide analog 5’-bromo-uridine (BrU) is 
added as a pulse to the cell culture medium to label nascent transcripts. At 
several time points after removal of BrU from the medium, RNA is isolated 
and BrU labeled RNAs are recovered by immunoprecipitation using antibodies 
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against BrU. Labeled RNAs with a high turnover rate will be lost quickly, 
whereas more stable RNAs will still be detectable long time after the pulse. 
The labeled RNAs can then be used for cDNA preparation, as BrU does not 
lead to misincorporation of nucleotides during reverse transcription. The 
abundance of specific RNAs can be analyzed by sequencing or qPCR 
assays. In comparison to ActD treatment, this method has the advantage that 
is does not block transcription, thus inducing less stress to the cells. 
Additionally, Tani et al. found that ActD affects the nuclear localization of the 
lncRNA MALAT1. This lncRNAs is usually found in the nuclear paraspeckles 
(Tani, Mizutani et al. 2012), a sub-compartment of the nucleus enriched with 
ribonucleoproteins that is involved in the regulation of gene expression (Bond 
and Fox 2009). Treatment of HeLa cells with a final ActD concentration of 
2µg/ml resulted in dissociation of MALAT1 from the paraspeckles and 
increased stability of the MALAT1 transcript (Tani, Mizutani et al. 2012). This 
finding demonstrates that ActD can act differently on the stability of RNAs, 
depending of their sub-cellular localization.  
 
4.9.2 Transcriptional pulsing (pulse chase)  
Another method to determine RNA stability is transcriptional pulsing. It makes 
use of an inducible promoter which quickly responds to an external stimulus. 
Thereby, transcription can be turned on and off by the experimenter. 
Examples are the c-fos promoter which can be induced by serum addition, or 
the Tet-off system  (Gossen and Bujard 1992), which allows to block gene 
expression upon tetracycline addition (Chen, Ezzeddine et al. 2008). After an 
initial pulse, the activator is removed and RNA abundance is examined at 
defined time points after the activator removal. Thereby, degradation kinetics 
can be followed. However, such systems depend on a transformation with the 
genes of interest and do not allow a genome wide screening.  
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4.9.3 Conclusion 
 
In contrast to the two alternative methods introduced above, ActD treatment 
provides a simple, easy applicable, and relatively inexpensive system. 
Additionally, I showed that ActD did not affect cell viability during 4-6 hours of 
treatment, and Airn and myc were reduced to levels consistent with their 
published half-lives. Despite the fact that the stability of a few RNAs like 
MALAT1 cannot be investigated, ActD treatment can be used for genome 
wide screenings. For example, a recent publication used ActD treatment of 
murine N2a cells to investigate half-lives of about 800 lncRNAs and 12.000 
mRNAs (Clark, Johnston et al. 2012). Taken together, I conclude that ActD is 
a suitable agent to assay the stability of short-lived lncRNAs and provides a 
reliable system to investigate RNA levels also on a genome wide basis.  
 
4.10 Is instability a general feature of long ncRNAs? 
 
In section 3.7. I showed that the imprinted macro lncRNAs Airn and Kcnq1ot1 
are relatively unstable. In contrast, the Airn splice variant SV1 was relatively 
stable and H19 RNA was upregulated upon ActD treatment. These results 
indicate that lncRNAs are not generally unstable, which is in accordance with 
published data that show that lncRNAs are a heterogenous class of RNAs 
with half-lives between several minutes to more than 48 hours. However, 
spliced lncRNAs were globally more stable than unspliced transcripts (Clark, 
Johnston et al. 2012; Tani, Mizutani et al. 2012); thus, instability could be a 
general feature of macro lncRNAs. It is possible that the three features 
instability, nuclear localization and inefficient splicing are closely linked to one 
other. This was demonstrated for Airn, where the spliced variants show 
increased stability over the unspliced transcript (Seidl, Stricker et al. 2006). 
Splicing also correlates with lncRNA localization, as unspliced Airn transcripts 
are retarded in the nucleus, whereas the splice variants are exported to the 
cytoplasm. Nuclear localization in turn was shown to be associated with 
reduced stability (Clark, Johnston et al. 2012). The shorter half-life of 
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unspliced lncRNAs hints on a regulatory function, as short-lived transcripts 
respond quickly to changes in their expression level. Additionally, a short half-
life implies that the RNA has no structural or scaffolding function. Thus, similar 
to short-lived transcription factor proteins, macro lncRNAs might function as 
transcriptional regulators. So far, it has been shown for a few macro lncRNAs 
in imprinted gene clusters that their function is to regulate imprinted gene 
expression (Sleutels, Zwart et al. 2002; Mancini-Dinardo, Steele et al. 2006; 
Williamson, Ball et al. 2011). At least for Airn, evidence is increasing that 
transcription is the only relevant mechanism required for epigenetic gene 
silencing by a macro lncRNA; thus the unspliced short-lived transcript is the 
functional Airn, whereas the more stable splice variants are not required for its 
gene regulatory function. 
 
A genome wide analysis by RNA sequencing of ActD treated samples will 
give further insight to the stability of lncRNAs in the mouse genome. 
Additionally, sequencing data will allow to further test for the effects of ActD 
on the transcriptome of the treated cells. As further macro lncRNAs are 
tested, more evidence will accumulate on the possible link between lncRNA 
stability and function. 
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5. Materials and methods 
5.1 Materials  
5.1.1 Cell lines  
 NIH3T3 
 H5 (+/FAP) 
 C8A8 (+/RAP) 
 R2∆ 1.3 (R2∆/+) 
 
5.1.2 Chemicals and consumables  
 
100bp+ ladder Fermentas 
1kb ladder Fermentas 
α32P-dATP Hartmann Analytic 
Acetic acid Applichem 
Actinomycin D Sigma 
Agarose  Biozym 
BCP MRC 
β-mercapto ethanol Invitrogen 
Betaine 5M Sigma 
Boric acid Applichem 
DNA ladder, 100bp+ Fermentas 
DNA ladder, 1kb Fermentas 
DMEM without Hepes Gibco 
DMEM+Hepes Invitrogen 
DMSO Sigma 
dNTP Mix 10mM Fermentas 
DPBS Gibco 
EDTA  Merck 
Ethanol 96% Merck 
Ethidiumbromide Applichem 
EtOH 96% Merck 
FCS PAA 
Formaldehyde 16%, methanol free Thermo Scientific 
Gelatin Sigma 
Gentamycin Invitrogen 
Glycogen  Roche 
HCl Merck 
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Hybond™ XL membrane Amersham 
Isopropanol Merck 
Isopropanol Merck 
L-Glutamine Invitrogen 
Mesa Green qPCR master mix Eurogentec 
MgCl2 25mM Fermentas 
MEM (Non-essential amino acids) Invitrogen 
PCI Applichem 
qPCR Mastermix Plus Eurogentec 
Retinoic Acid (RA) Sigma 
RNA storage solution  Ambion 
RNase Zap Spray Ambion 
RNase Zap Wipes Ambion 
Sephadex™ G-50 Amersham 
Sodium acetate (NaAc), 3M Ambion 
TRI reagent Sigma 
Tris  Applichem 
TRIzol Invitrogen 
Trypsin 0,25% EDTA, red Invitrogen 
Trypsin 0,5% EDTA, white Invitrogen 
Water for Embryo Transfer Sigma 
 
5.1.3 Enzymes and buffers  
MluI Fermentas 
Buffer R Fermentas 
Buffer O Fermentas 
BglII Fermentas 
NotI Fermentas 
Klenow Fragment Fermentas 
RNase A Fermentas 
Proteinase K Applichem 
GoTaq DNA polymerase Fermentas 
5x GoTaq flexi buffer Fermentas 
 
5.1.4 Antibodies  
against company catalog # lot# 
H3K4me3 upstate 07-473 608038479 
IgG (part of EZ Chip kit) Millipore   
Pol2(part of EZ ChIP kit) Millipore   
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5.1.5 Kits  
EZ-ChIP™ Chromatin Immunoprecipitation Kit Millipore 
Wizard®  SV Gel and PCR Clean-up System Promega 
RevertAid™ First Strand cDNA Synthesis Kit Fermentas 
DNA-free™ Kit Ambion 
 
5.1.6 Solutions and Media 
 
ES cell medium: 
FCS (fetal calf serum) 30 ml 
Gentamycin 1,0 ml 
L-glutamine 2, 0ml 
MEM  2,0 ml 
β-mercapto ethanol 400 µl 
sodium pyruvate 2,0 ml 
DMEM w/o Hepes up to 200ml 
LIF different  
 
ES cell differentiation medium: ES cell medium without LIF and supplemented 
with 0.27µM retinoic acid. 
 
Fibroblast medium: 
 FCS 20 ml 
 Gentamycin  1,0 ml 
 L-glutamine 2,0 ml 
 DMEM up to 200ml 
 
Freezing medium 
 FCS 80% 
 DMSO 20% 
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DNA lysis solution, was always prepared freshly before use: 
1% SDS 
0,5 mg/ml Proteinase K  
1xTEN pH 9.0 (250 mM Tris pH 9,0; 100mM EDTA pH 8,0; 200mM 
NaCl) 
 
LS mix: 
25ml 1M Hepes pH 6.6 
1 ml OL (50 units of hexamers dissolved in 1,6ml TE pH8.0) 
25ml TM (250mM Tris pH 8.0; 25mM MgCl2; 50mM ß-mercaptoethanol) 
 
CTG mix: 
100µM dCTP 
100µM dTTP 
100µM dGTP 
2 mg/µl BSA 
 
Denaturing solution: 
0.5M NaOH 
1.5M NaCl 
 
Church buffer: 
250mM Na2HPO4 
7% SDS 
1mM EDTA 
 
Church wash buffer: 
1% SDS 
20mM Na2HPO4 
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Southern blot hybridization probes: 
 EN4kb 
 OT2.4 
 
10x Loading dye: 
 125mg 0.5% Xylenol orange 
 7.5 ml 30% Glycerol 
 17.5 ml 1xTAE 
5.1.7 PCR probes and primers  
 
Taqman assays: 
Air-middle:  
Forward: 5’-GACCAGTTCCGCCCGTTT-3’ 
Reverse: 5’-GCAAGACCACAAAATATTGAAAAGAC-3’ 
Taqman probe: 5’-FAM-TACAAGTGATTATTAACTCCACGCCAGCCTCA-
TAMRA-3’ 
 
Airn SV1:  
Forward: 5’-AAGCACAGCACCGCCAGT-3’ 
Reverse: 5’-CCATGTCCTTTCTTTTCCACTACC-3’ 
Taqman probe: 5’-FAM-CCACGCAGACATCMGB-3’ 
 
Kcnq1ot1 (Lit1): 
Forward: 5’-GCCCAAACCTTAGTCCTCCAT-3’ 
Reverse: 5’-GAAAGCACTCCTCCCCATTT-3’ 
Taqman probe: 5’-FAM-TTGTTGTTCTTGTTGGTCACATTCCCTTTTCT-
TAMRA-3’ 
 
H19: 
Forward: 5’-CATCCAGCCTTCTTGAACACC-3’ 
Reverse: 5’-GGGAAAAGTGAAAGAACAGACGG-3’ 
Taqman probe: 5-FAM-TGGGCTGGCGCCTTGTCGTAG-TAMRA-3’ 
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Gapdh-ex5: 
Forward: 5’-CATGGCCTTCCGTGTTCCTA-3’ 
Reverse: 5’-TGTCATCATACTTGGCAGGTTT-3’ 
Taqman probe: 5’-FAM-TCGTGGATCTGACGTGCCGCC-TAMRA-3’ 
 
Cyclophilin A 
Forward: 5’-AGGGTTCCTCCTTTCACAGAATT-3’ 
Reverse: 5’-GTGCCATTATGGCGTGTAAAGT-3’ 
Taqman probe: 5’-FAM-TCGTGGATCTGACGTGCCGCC-TAMRA-3’ 
 
SYBR green assay Primers: 
 
myc-ex2/3 
Forward: 5’-GAGCCCCTAGTGCTGCAT-3’ 
Reverse: 5’-CCACAGACACCACATCAATTTCTT-3’ 
 
18S-2 
Forward: 5’-ACATCCAAGGAAGGCAGCAG-3’ 
Reverse: 5’-TCGTCACTACCTCCCCGG-3’ 
 
 
Primers for non-quantitative PCR: 
 
Primers which cover the Airn promoter region   
Name forward reverse 
product 
size 
(bp) 
1 AGTGGGTGGTAGGAATAGGG GCCTCTGAGCAGTTTCCTG 428 
2 GGGTGAAGGAAGTGTCTCAC CCCACTCTCCAACTTAAAGC 507 
3 CATGAAGGACTGACAGAACTAACC TTACACCTGATCCTACTGTCCTG 303 
4 AGTCAGGGTGTGGATTCTGC GCAGAGAACGAATCATCCAAG 418 
5 GGCTTGCCTAGTGCTTATCTG TGCTCTGCAACATGACCTC 518 
6 TCACCCTAGCGCTGAATCTC TCCAGGACTGTAAGGCCATC 473 
7 CCCTGATCACAGAACCCTTC AGGGTGAAAAGCTGCACAAG 405 
8 CAGAGGAGGTGGGAACAATG GCATTTCGAGTGGATTCAGG 520 
9 GGCCTGAGAGCCATTTAAACTTAG CCTGAGATCCAAATAGGGTGTG 420 
10 ACAGATGCTCCGCTTCCAG GTCTGAGGGCTGCCAAATAAC 545 
11 AAGCACCACAGTTCATGCTG AGCCTCAGCCACTCAAGATG 443 
12 AAGAGCTGAAGGCAGCCATA TGAAGTCTAAAGTCACGGCACA 401  
  80 
 
    
Primers which cover the Igf2r promoter region   
Name forward reverse product size [bp] 
13 TTTGACTTTTGACCCCTTGG  TCAGCAACAGAGAGGGAAGG 111 
14 CTTCTGAGCTTGGCACAC  AGGCAGCTCTGCTTCTG 192 
15 GAAGAGGCCAGGTAATGCAG  GTACACAAACGGAGGTGATCC 408 
16 AGGCAGCTCCTTATGTGGTC  ACCGTGCTGTTCCAGTAACC 506 
17 CACTTGTGCATGGTCATCTC  AACAGCTGCCTAGCTTGC 412 
18 AGCCATTTGTCAGTGGTTGAAG  TCAGCCCCGTCTCATTCTG 417 
19 TCCACCAGTCACCTAACTTGC  CCGGGTCACATGAGCATC 412 
20 GTGCTCCATTTCCAAAGC  GGAGTTCATGTTTGTCCTCTC 163 
21 AAAGCACAACATACCCATACAG  CGGGTGCCATAGATTAACCA 159 
22 CTCTAGGGCAGTGTCTCACG  TGCTATGACTTATATTGGCATCC 150 
23 TCATTTATCTCTGAAGGCAAGG  GAATTACTTAGTGACCTCCCTTCC 410 
24 AGAAGGGGCAACAGATGAAC  GAAGGCGATTGAAAGTCACAG 458 
Igf2r-MluI-
low CACGCAAGACACCCACCT CTTCGACTCCGCTGTGGT 232 
Igf2r-MluI-
seq CCCTCCAGCTCCCGTTGCAG GGAGTTCCCAGGGTCTTCCCACA 506 
 
 
primers used for sequencing 
low-seq F3 CTGCACAGGGCGTCCAAGT  
low-seq R1 TTCGACTCCGCTGTGGTG  
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5.2 Methods 
 
5.2.1 Chromatin immunoprecipitation 
Used the EZ ChIPTM Kit from Millipore according to the manufacturers 
instructions. The following changes to the protocol were made: for using IgM 
subclass antibodies (H5, H14) Anti Mouse IgM Sepharose beads were used.  
Pre-clearing was optimized to use 120µl of Protein G Agarose beads instead 
of 60µl. For sonication of chromatin, a Covaris Sonolite device with the 
following conditions was used: duty cycle: 50%, intensity: 10%, cycles per 
burst: 500, cycle time: 480s. The conditions were optimized to use 2 or 3 
sonication cycles.  
 
5.2.2 Phenol-Chloroform-Extraction 
All samples were brought to a volume of 500µl with embryo transfer water 
(Sigma). 500µl of PCI was added and the samples vortexed. Tubes were 
centrifuged at 13.000 rpm for 10 min at room temperature. 450µl of the upper 
phase were transferred into fresh tubes and mixed with 450µl chloroform and 
spun again as before. 400µl of the upper phase were transferred into new 
tubes and 40µl 3M NaAc, 2µl glycogen (20mg/ml) and 800µl EtOH were 
added. The tubes were put to -20ºC over night or longer to allow small 
fragments to precipitate.   
 
5.2.3 Isolation of genomic DNA 
Cell pellets were resuspended in DNA lysis solution and incubated at 55°C 
over night. To 700µl of lysis solution 300µl of saturated NaCl solution were 
added and tubes mixed by hand for 20 seconds. Tubes were spun at 14.000 
rpm (eppendorf centrifuge) for 10 min at RT. Supernatant was transferred into 
a fresh tube containing 600µl isopropanol. Tubes were shaken by hand until a 
precipitate was seen in all tubes.  Tubes were spun at RT 14.000rpm, 
supernatant discarded and pellet washed with 70% EtOH (15 min, shake 
every 5 min). Tubes were spun again and remaining EtOH removed carefully. 
The DNA pellet was dissolved in 100µl TE and incubated at 55°C over night. 
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5.2.4 Southern blotting 
Approximately 20µg of genomic DNA were digested in a 40µl reaction with 20 
units of the corresponding enzyme and appropriate buffers. Digested DNA 
samples were mixed with a 10x loading buffer and together with a 1kb ladder 
loaded on a 0,8% agarose in 1xTBE gel. Electrophoresis was carried out at 5 
V/cm for 3.5 hours. The gel was stained in ethidiumbromide solution for 1 
hour and a photo taken. The DNA was denatured twice with denaturing 
solution for 30min on a shaker.  
 
Blotting: 
The gel was placed on Whatman papers soaked in denaturing solution with 
the ends dipping into the solution. A Hybond™ XL nylon membrane soaked in 
denaturing solution was placed on top of the gel and covered with 3 layers of 
Whatman paper. Air bubbles were removed by carefully rolling over the 
membrane and Whatman papers with a 10 ml plastic pipette. The area around 
the gel was covered with plastic strips to avoid buffer shortcut. About 10cm of 
paper towels were put onto the blot and a glass plate put on top and weighed 
down with a blot weight. After 1-2 days the blots were disassembled and the 
membrane washed in 20mM Na2HPO4 for 2 min.  
 
Probe labelling: 
20ng of the probe were diluted with H2O to a volume of 14µl, denatured at 
100°C for 5 min and put on ice for 2-3 min. To the probe 20µl LS, 6 µl CTG 
mix, 1µl Klenow fragment and 2µl α32P-dATP were added, and left over night 
at RT.  Next day the probe was diluted with 60µl TE and cleaned by 
centrifugation over a packed Sephadex™ G-50 column (300rpm at RT for 3 
min.) to remove unincorporated nucleotides.  
 
Hybridization of the blot: 
The membrane was pre-hybridized with Church buffer for a minimum of 30 
min to 3h at 65ºC. The labelled probe was denatured at 100°C for 5 min and 
then put on ice for 2 min to keep it denatured. Pre-hybridization buffer was 
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removed from the membrane and the labelled probe together with 10ml 
church buffer was added. The blot was hybridized at 65ºC under permanent 
rotation for a minimum of 18 hours. After hybridization the membrane was 
washed twice with church wash buffer at 65 °C.  
 
Visualization: 
The blots were sealed in foil and an imaging plate (Fujifilm) was exposed to 
each blot for 1-3 days. The imaging plate was scanned with the Typhoon Trio 
Variable mode Imager (GE healthcare) and images were adjusted for 
brightness and contrast using Adobe Photoshop.  
 
5.2.5 RNA isolation from cells  
Medium was removed from cells, TriReagent or TRIzol added (2ml were used 
for one 10cm dish) and cells scraped from dishes. The cell suspension was 
left at room temperature (RT) for 5 min. before putting it to -20ºC 
The suspension was thawed on ice and 1 ml transferred to RNA tubes. 100µl 
BCP were added per tube, mixed by shaking the tubes by hand and left at 
room temperature for 10 min. Tubes were centrifuged with 13.000rpm for 15 
min at 4ºC. The upper phase was transferred into a new RNA tube and 500µl 
isopropanol were added, mixed and left at RT for 10 min. The tubes were 
again centrifuged (see above). The whole supernatant was removed and the 
RNA pellet washed with 1 ml 70% EtOH. Following another round of 
centrifugation, remaining EtOH was carefully removed and the pellet 
dissolved in 100µl RNA-storage-solution (RSS). To precipitate RNA from 
100µl RSS, 10µl 3M NaAc and 250µl 96% EtOH were added and the tubes 
stored at -20ºC. 
 
5.2.6 cDNA preparation (first strand synthesis) 
The cDNA was prepared from either 6µg or 4µg of DNAseI treated RNA. 
cDNA preparation used the DNAfree kit (Ambion) and the Revert aid kit 
(Fermentas) according to manufacturers instructions. 
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5.2.7 Non-quantitative PCR 
Standard PCR was performed in 25µl reactions containing 0.5 units GoTaq 
polymerase (Fermentas), 1x GoTaq flexi buffer (Fermentas), 200 µM dNTPs, 
2.5mM MgCl2, 0.8M betaine, 500µM forward primer, 500µM reverse primer. 
PCR with the primer pair “Igf2r low” was optimized to use 1.5mM MgCl2. PCR 
for Gapdh used 1.5mM MgCl2 and no betaine.  
 
PCR programs: 
-) ChIP-PCR 
Denaturing at 94ºC 3min, 35cycles of 96ºC for 10 sec, 94ºC for 30sec, 58ºC 
for 1min and 72ºC for 1min, final extension at 72ºC for 5 min.  
-) PCR program for PCR with Gapdh specific primers: 
Denaturing at 94ºC 3min, 25 or 30 cycles of 96ºC for 10 sec, 94ºC for 30sec, 
58ºC for 30sec and 72ºC for 30sec, final extension at 72ºC for 5 min.  
 
PCR products were analyzed by electrophoresis on 1,5 or 2% agarose gels in 
TAE buffer with 5 to 8 V/cm. Following electrophoresis, the gels were stained 
in Ethidiumbromide solution for approx. 1 hour. Bands were visualized with a 
UVsoloTS imaging system device.  
 
5.2.8 Quantitative real-time PCR (qPCR) 
Reactions were performed in 25µl reactions on 96-well PCR plates.  
Machine: 7900HT Fast Real Time PCR system, Applied biosystems 
Software: Sequence detection system version 2.3, Applied biosystems 
 
Taqman assays used 900nM of forward and reverse primers and 200nM 
Taqman probe. SYBR green assays used 100nM of forward and reverse 
primers. Reactions were carried out in 25µl including 5µl cDNA and 20µl 
qPCR mastermix with the following conditions: Initial denaturation at 95ºC for 
5min, followed by 40 cycles of 95ºC for 15sec and 60ºC for 1 min (the Airn-
SV1 assay used 62ºC). SYBR green qPCR used an additional dissociation 
step from 60 to 65ºC for 1min. Quantitation used the standard curve method 
for calculating the relative amounts of cDNA. +RT reactions were carried out 
  85 
as triplicates and –RT reactions as duplicates. Results were normalized to a 
housekeeping gene. Standard curves were derived from serial dilutions of 
cDNA. The results were analysed and displayed using MS Office Excel. 
 
5.2.9 ES cell culture 
The ES cells were cultured on growth inhibited feeder cells and cultured in ES 
cell medium containing LIF (leukemia inhibitory factor) at 37ºC, 5% CO2 until 
they reached the sufficient density to be used for differentiation. During this 
period, the ES cells were fed every day with fresh medium. After feeder 
depletion, the cells were transferred to fresh gelatinized dishes and cultured in 
differentiation medium. The day the ES cells were transferred to the 
differentiation plates was set as day0 and cells were harvested for the 
experiments at day5 of differentiation.  
 
Feeder depletion: 
ES cells grown on feeders were trypsinized and resuspended in 10 ml ES cell 
medium. The cell suspension was transferred to a fresh 10cm dish. After 20 
min, the medium was carefully removed and transferred to falcon tube. 
Feeder cells remain attached to the dish. ES cells were count and the 
required number plated to new gelatinized dish. 
 
ES cell differentiation 
1.3x106 cells were plated on gelatinized 15cm dishes with 20ml differentiation 
medium. The day of plating the cells was set as day0. Cells were fed every 
second day during differentiation and harvested at day5. For ChIP, cells were 
in vivo crosslinked with 1% formaldehyde (15ml medium +1ml 16% 
formaldehyde, methanol free (Thermo Scientific)) 
 
5.2.10 Fibroblast cell culture 
NIH3T3 cells were maintained in Fibroblast medium, 37ºC, 5% CO2. Cells 
were split in a 1:3 ration when they reached a confluence of about 90%. 
 
  86 
5.2.11 Thawing cells 
Tubes containing the cells were taken from liquid nitrogen and put on dry ice. 
The cells were thawed in 37ºC waterbath, transferred to cell culture hood and 
resuspended in 10ml medium. Tubes were spun with 1050 rpm for 5 min. and 
the supernatant discarded. The cell pellets were resuspended in appropriate 
volume of medium and the cell suspension plated on 10cm dishes. 
 
5.2.12 Freezing cells 
Cells from a confluent 10cm dish were resuspended in 1.5 ml medium. 0.5 ml 
of cell suspension were transferred to labelled cryotubes, and 0.5 ml freezing 
medium added. Tubes were closed, inverted to mix and immediately put on 
ice. When all tubes were processed, they were placed into a freezing 
container (“Mr. Frosty”, NALGENE), which was then put into a -80˚C freezer 
for 24h. Then the tubes were transferred to liquid nitrogen. 
 
5.2.13 DNA sequencing 
PCR products were purified with Promega Wizard SV kit, and 100µg of DNA 
dissolved in 12µl nuclease free water, together with 2µl of 10µM primer were 
sent to the company LGC genomics for sequencing.  
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